RESULT_COUNT: 413,PAGE_SIZE: 10000,CURRENT_PAGE: 1,TOTAL_PAGES: 1,API_CALL_CREDITS: 1
TICKER,FIGI_TICKER,FIGI,TITLE,PUBLICATION_DATE,URL,SUMMARY
MYGN,MYGN:UW,BBG000D9HMX2,"Zacks.com featured highlights: Tyson Foods, Movado Group, Myriad Genetics, PRA Health Sciences and Urstadt Biddle Properties",2017-10-19 13:03:01 +0000,https://finance.yahoo.com/news/zacks-com-featured-highlights-tyson-130301848.html?.tsrc=rss,"Zacks.com featured highlights: Tyson Foods, Movado Group, Myriad Genetics, PRA Health Sciences and Urstadt Biddle Properties"
MYGN,MYGN:UW,BBG000D9HMX2,Today's Research Reports on Trending Tickers: Myriad Genetics and Strata Skin Sciences,2017-10-19 12:00:00 +0000,https://finance.yahoo.com/news/todays-research-reports-trending-tickers-120000131.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / October 19, 2017 / All three major Indexes closed in the green Wednesday on the latest batch of corporate earnings, with the Dow Jones Industrial Average closing above the 23,000 ..."
MYGN,MYGN:UW,BBG000D9HMX2,GeneSight® Shown to Statistically Significantly Improve Generalized Anxiety Disorder Treatment Response and Decrease Benzodiazepine Use,2017-10-19 11:05:00 +0000,https://finance.yahoo.com/news/genesight-shown-statistically-significantly-improve-110500946.html?.tsrc=rss,"SALT LAKE CITY, Oct. 19, 2017-- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced new positive results for the GeneSight ® test in patients with Generalized Anxiety Disorder. ..."
MYGN,MYGN:UW,BBG000D9HMX2,Assurex: Study Shows GeneSight Statistically Improves Treatment Response In GAD,2017-10-19 08:05:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_t3Nqsn0IxE/assurex-study-shows-genesight-statistically-improves-treatment-response-in-gad-20171019-00623,Assurex: Study Shows GeneSight Statistically Improves Treatment Response In GAD
MYGN,MYGN:UW,BBG000D9HMX2,Buy 5 Low-Beta Stocks & Forget Market Volatility,2017-10-18 14:55:45 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DrVrz_DNh_c/buy-5-low-beta-stocks-forget-market-volatility-cm861260,For generating handsome returns one has to invest in risky stocks This seems to be a thumb rule for most investors The strategy works extremely well for securities or portfolios that are directly correlated with the market But the converse scenario should also be taken into account
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s BRACAnalysis CDx® Supplementary PMA Accepted by FDA for Review as a Companion Diagnostic for Lynparza® (olaparib) in Metastatic Breast Cancer,2017-10-18 11:00:00 +0000,https://finance.yahoo.com/news/myriad-bracanalysis-cdx-supplementary-pma-110000550.html?.tsrc=rss,"SALT LAKE CITY, Oct. 18, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that the U.S. Food and Drug Administration has accepted its supplementary ..."
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : October 17, 2017",2017-10-17 13:52:25 +0000,http://finance.yahoo.com/r/d0c46893-45d6-34a1-a19f-e4e78e678f7a/etfs-with-exposure-to-myriad-genetics-inc-october-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,3 Signs Myriad Genetics' High-Growth Days Are Over,2017-10-12 13:14:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DQDZEk_SUmQ/3-signs-myriad-genetics-high-growth-days-are-over-cm858594,Myriad Genetics NASDAQ MYGN used to be the creme de la creme of the genetic testing industry It had healthy profit margins a growing business and was well known among investors and health professionals 160 But the party was busted up in 2015 While the company s
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-10-12 12:05:13 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120513665.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,3 Signs Myriad Genetics&apos; High-Growth Days Are Over,2017-10-12 11:47:00 +0000,https://finance.yahoo.com/news/3-signs-myriad-genetics-apos-114700156.html?.tsrc=rss,The genetic testing leader may never return to its former glory.
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : October 6, 2017",2017-10-06 14:57:59 +0000,http://finance.yahoo.com/r/4fd525e1-294b-306e-b543-1bb93fbdbdc8/etfs-with-exposure-to-myriad-genetics-inc-october-6-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017",2017-10-05 13:27:24 +0000,http://finance.yahoo.com/r/5f8a20a3-55ac-3505-af76-fe5bead9230a/myriad-genetics-inc-mygn-us-earnings-analysis-q4-2017-by-the-numbers-october-5-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Myriad Genetics, Inc. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 200.50 million, Net Earnings of USD 12.90 million. Gross margins widened from 78.55% to 78.80% compared to the same period last year, operating (EBITDA) margins now 25.99% from 22.73%. Change in operating ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Highlights Strong Commitment to Preventing and Fighting Breast Cancer as Part of Breast Cancer Awareness Month,2017-10-02 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-highlights-strong-commitment-110500059.html?.tsrc=rss,"SALT LAKE CITY, Oct. 02, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, continues to demonstrate an unmatched commitment to hereditary cancer risk assessment ..."
MYGN,MYGN:UW,BBG000D9HMX2,Improved Outlook for Myriad Genetics,2017-09-21 18:43:00 +0000,https://finance.yahoo.com/news/improved-outlook-myriad-genetics-184300808.html?.tsrc=rss,We're raising our fair value estimate on the narrow-moat firm after the unveiling of a new cancer product.
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Presents Favorable riskScore Test Data,2017-09-18 15:42:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Ien3eVcngpA/myriad-genetics-presents-favorable-riskscore-test-data-cm847089,Myriad Genetics Inc MYGN presented encouraging medical tool riskScore test data It also announced favorable study results for its myRisk Hereditary Cancer suite The results were presented at the 36 th 160 annual conference of the National Society of Genetic Counselors NSGC in
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Presents Favorable riskScore Test Data,2017-09-18 13:24:01 +0000,https://finance.yahoo.com/news/myriad-genetics-presents-favorable-riskscore-132401138.html?.tsrc=rss,"Myriad (MYGN) presenting positive riskScore data at the NSGC conference in Columbus, OH buoys optimism. Notably, with riskScore the company intends to boost its myRisk Hereditary Cancer test suite."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Announces Positive Data Supporting New riskScore™ Test at the 36th Annual Conference of the National Society of Genetic Counselors,2017-09-15 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-announces-positive-data-110500220.html?.tsrc=rss,"SALT LAKE CITY, Sept. 15, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that two important studies will be featured in podium presentations ..."
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-09-12 12:08:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120817452.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present Three Studies at the 2017 National Society of Genetic Counselors Annual Conference,2017-09-12 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-three-studies-110500568.html?.tsrc=rss,"SALT LAKE CITY, Sept. 12, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it will present results from three studies at the National Society ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Present At Morgan Stanley Conference; Webcast At 10:35 AM,2017-09-12 09:36:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/jSOWtNUgZIY/myriad-genetics-to-present-at-morgan-stanley-conference-webcast-at-1035-am-20170912-00850,Myriad Genetics To Present At Morgan Stanley Conference; Webcast At 10:35 AM
MYGN,MYGN:UW,BBG000D9HMX2,Today's Research Reports on Stocks to Watch: Sarepta Therapeutics and Myriad Genetics,2017-09-07 12:10:00 +0000,https://finance.yahoo.com/news/todays-research-reports-stocks-watch-121000834.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / September 7, 2017 / It was a big day for biotech companies Sarepta Therapuetics and Myriad Genetics on Wednesday. Both stocks soared, with Myriad even hitting a new 52-week ..."
MYGN,MYGN:UW,BBG000D9HMX2,Hereditary Cancer Risk Assessment Is an Important Option for Prostate Cancer Patients during Prostate Cancer Awareness Month,2017-09-07 11:05:00 +0000,https://finance.yahoo.com/news/hereditary-cancer-risk-assessment-important-110500681.html?.tsrc=rss,"SALT LAKE CITY, Sept. 7, 2017 /PRNewswire/ -- Myriad Genetics, Inc. (MYGN), a leader in molecular diagnostics and personalized medicine, is working to educate the public about hereditary cancer risk assessment and testing during Prostate Cancer Awareness Month this September.  With 2.9 million men living with prostate cancer, it is now the second leading form of cancer in the United States, killing one man every 19 minutes.  Up to 15 percent of prostate cancers are due to an inherited mutation.  Myriad's myRisk® Hereditary Cancer test is an effective tool to assess genetic mutations in men diagnosed with prostate cancer."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Present At Wells Fargo Conference; Webcast At 8:50 AM ET,2017-09-07 07:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vIfNbNrrWg8/myriad-genetics-to-present-at-wells-fargo-conference-webcast-at-850-am-et-20170907-00455,Myriad Genetics To Present At Wells Fargo Conference; Webcast At 8:50 AM ET
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Boosts myRisk Hereditary Cancer Test Suite,2017-09-06 14:54:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Q3tR6cZALvw/myriad-genetics-boosts-myrisk-hereditary-cancer-test-suite-cm841656,Myriad Genetics Inc MYGN introduced riskScore under its myRisk Hereditary Cancer testing portfolio The launch is aimed at solidifying the company s footprint in the rapidly growing hereditary cancer testing market Based in Salt Lake City UT this leading molecular diagnostics
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Boosts myRisk Hereditary Cancer Test Suite,2017-09-06 13:13:01 +0000,https://finance.yahoo.com/news/myriad-genetics-boosts-myrisk-hereditary-131301852.html?.tsrc=rss,"Myriad Genetics (MYGN) introduces riskScore, a breast cancer prediction tool to broaden its myRisk hereditary cancer test offerings."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Launches riskScore™ Beginning the Next Epoch in Hereditary Cancer Testing,2017-09-05 20:05:00 +0000,https://finance.yahoo.com/news/myriad-launches-riskscore-beginning-next-200500472.html?.tsrc=rss,"SALT LAKE CITY, Sept. 05, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that it has launched riskScore™, a new clinically validated precision ..."
MYGN,MYGN:UW,BBG000D9HMX2,"The 2 Major Catalysts Behind Myriad Genetics, Inc.'s 26% Gain in August",2017-09-05 18:50:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dIAwFYfnjTU/the-2-major-catalysts-behind-myriad-genetics-incs-26-gain-in-august-cm841161,What happened Shares of Myriad Genetics NASDAQ MYGN a leading developer of molecular diagnostic tests surged by 26 during the month of August according to data from S amp P Global Market Intelligence Why the sudden surge The bulk of the gains look traceable to
MYGN,MYGN:UW,BBG000D9HMX2,"The 2 Major Catalysts Behind Myriad Genetics, Inc.&apos;s 26% Gain in August",2017-09-05 16:47:00 +0000,http://finance.yahoo.com/r/0fc0db30-c290-353a-a6a0-9473ab350059/the-2-major-catalysts-behind-myriad-genetics-incs.aspx?yptr=yahoo&.tsrc=rss,Hint: they both involve the company&apos;s new diagnostic products.
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-09-02 12:10:25 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-121025132.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,5 of the Most Hated Biotech Stocks on the Market: Are They Buys?,2017-09-01 17:51:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/EB5cOEDEbtk/5-of-the-most-hated-biotech-stocks-on-the-market-are-they-buys-cm840392,One of the best ways to measure how much a stock is hated is by looking at the percentage of the stock s float that s sold short Short sellers 160 think so poorly of a stock that they re willing to put money on the line that its price will fall Five biotech stocks appear
MYGN,MYGN:UW,BBG000D9HMX2,5 of the Most Hated Biotech Stocks on the Market: Are They Buys?,2017-09-01 16:08:00 +0000,http://finance.yahoo.com/r/bc52e4db-371e-34e7-92b0-884a5d7c705f/5-of-the-most-hated-biotech-stocks-on-the-market-a.aspx?yptr=yahoo&.tsrc=rss,"Short-sellers have piled on Agios, Insys, Intercept, Lexicon, and Myriad Genetics. But are they wrong?"
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-09-01 12:03:46 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120346322.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2017 Morgan Stanley Global Healthcare Conference,2017-08-30 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-2017-morgan-110500020.html?.tsrc=rss,"SALT LAKE CITY, Aug. 30, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2017 Wells Fargo Healthcare Conference,2017-08-29 20:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-2017-wells-200500512.html?.tsrc=rss,"SALT LAKE CITY, Aug. 29, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the ..."
MYGN,MYGN:UW,BBG000D9HMX2,5 Stocks at 52-Week Highs: Are They Buys?,2017-08-27 16:49:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-Patyk-37xk/5-stocks-at-52-week-highs-are-they-buys-cm837650,How high can they go That s the most pressing question for five stocks that recently hit 52 week highs Autohome NYSE ATHM Brookfield Infrastructure Parners NYSE BIP Myriad Genetics NASDAQ MYGN Procter amp Gamble NYSE PG and Weibo NASDAQ
MYGN,MYGN:UW,BBG000D9HMX2,5 Stocks at 52-Week Highs: Are They Buys?,2017-08-27 15:04:00 +0000,http://finance.yahoo.com/r/be7bbcf9-05a6-3240-b024-b7e1a8d31b4e/5-stocks-at-52-week-highs-are-they-buys.aspx?yptr=yahoo&.tsrc=rss,"Autohome, Brookfield Infrastructure Partners, Myriad Genetics, Procter & Gamble, and Weibo are hot stocks. But can their momentum continue?"
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : August 24, 2017",2017-08-24 19:44:36 +0000,http://finance.yahoo.com/r/90c407ac-693e-3a79-8259-04fceb4f517a/etfs-with-exposure-to-myriad-genetics-inc-august-24-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-08-24 12:06:17 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120625250.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,Featured Company News - Myriad Genetics' EndoPredict Receives Positive Coverage Decisions from Palmetto and Anthem,2017-08-22 11:00:00 +0000,https://finance.yahoo.com/news/featured-company-news-myriad-genetics-110000705.html?.tsrc=rss,"Research Desk Line-up: Bioanalytical Systems Post Earnings Coverage LONDON, UK / ACCESSWIRE / August 22, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Health Care Sector Update for 08/18/2017: MYGN,THC,BSTG",2017-08-18 20:37:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3c_Pan11Vkg/health-care-sector-update-for-08182017-mygnthcbstg-cm834176,Top Health Care StocksTop Health Care Stocks JNJ 0 26 JNJ 0 26 PFE 0 83 PFE 0 83 ABT 0 99 ABT 0 99 MRK 0 49 MRK 0 49 AMGN 0 26 AMGN 0 26 Health care stocks have gone from narrowly mixed to moderately lower just before Friday s closing bell with the NYSE Health Care Index
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' EndoPredict Gets Positive Coverage Decision,2017-08-18 16:42:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ZJEHBtq6q0s/myriad-genetics-endopredict-gets-positive-coverage-decision-cm834025,Molecular diagnostics and personalized medicine major Myriad Genetics Inc MYGN achieved another milestone as its EndoPredict test got positive coverage decision from Palmetto GBA a Medicare Administrative Contractor that assesses molecular diagnostic technologies Notably EndoPredict
MYGN,MYGN:UW,BBG000D9HMX2,Increased Confidence Earns Myriad Genetics An Upgrade,2017-08-18 14:28:07 +0000,https://finance.yahoo.com/news/increased-confidence-earns-myriad-genetics-142807684.html?.tsrc=rss,"Deutsche Bank upgraded Myriad Genetics, Inc. (NASDAQ: MYGN ), as it believes the risk/reward is now balanced following the company below-consensus sales and earnings per share guidance for 2018. The firm ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics&apos; EndoPredict Gets Positive Coverage Decision,2017-08-18 14:14:02 +0000,https://finance.yahoo.com/news/myriad-genetics-apos-endopredict-gets-141402693.html?.tsrc=rss,"Considering Myriad Genetics&apos; (MYGN) EndoPredict has been used clinically in more than 15,000 patients, we are confident about the growing adaptability of this test post the Medicare coverage approval."
MYGN,MYGN:UW,BBG000D9HMX2,Biotech Movers: Jazz Shares Lower Amid Notes Offering,2017-08-18 13:56:00 +0000,http://finance.yahoo.com/r/686680d6-6751-3451-8012-0347ff22ae91/biotech-movers-jazz-shares-lower-amid-notes-offering.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,The Dublin firm announced an offering of $500 million of exchangeable senior notes due 2024.
MYGN,MYGN:UW,BBG000D9HMX2,Health Care Sector Update for 08/18/2017: MYGN,2017-08-18 13:38:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/7VPk7TntvSU/health-care-sector-update-for-08182017-mygn-cm833823,Top Health care stocks Top Health care stocks JNJ 0 2 JNJ 0 2 PFE 0 2 PFE 0 2 ABT flatABT flat MRK flatMRK flat AMGN flatAMGN flat Health care shares were mainly unchanged in pre market trade Friday Health care shares were mainly unchanged in pre market trade Friday In health
MYGN,MYGN:UW,BBG000D9HMX2,EndoPredict® Receives Positive Coverage Decisions From Medicare and Anthem,2017-08-17 20:15:00 +0000,https://finance.yahoo.com/news/endopredict-receives-positive-coverage-decisions-201500509.html?.tsrc=rss,"SALT LAKE CITY, Aug. 17, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that Palmetto GBA, the Medicare contractor who oversees the MolDx program ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Commit To Buy Myriad Genetics At $24, Earn 12.1% Annualized Using Options",2017-08-17 16:36:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/mMWUHh9IGZU/commit-to-buy-myriad-genetics-at-24-earn-121-annualized-using-options-cm833375,Investors considering a purchase of Myriad Genetics Inc Symbol MYGN shares but cautious about paying the going market price of 27 82 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is
MYGN,MYGN:UW,BBG000D9HMX2,3 Stocks Set to Pop,2017-08-16 19:36:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nc6xr8mgUZM/3-stocks-set-to-pop-cm832953,Individual investors should never attempt to time the market because well no one can time the market It s much better to buy great companies taking aim at unaddressed opportunities within reach of their technology platforms and sit pat for the long haul Smoothing over an industry s
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-08-16 12:05:28 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120528397.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-08-15 12:05:50 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120550939.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: 2017 By the Numbers : August 14, 2017",2017-08-14 18:40:44 +0000,http://finance.yahoo.com/r/fe901e34-03ae-3c1f-a28f-7ea4fd3462ef/myriad-genetics-inc-mygn-us-earnings-analysis-2017-by-the-numbers-august-14-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Myriad Genetics, Inc. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of Myriad Genetics, Inc. – Genomic Health, Inc., Foundation Medicine, Inc., Vermillion, Inc., BioMarin Pharmaceutical Inc., Exact Sciences Corporation, Biocept, Inc., Bio-Rad Laboratories, Inc. Class A, Trovagene, Inc. and ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes,2017-08-14 16:38:40 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/pfEwW8TCFn4/myriad-genetics-mygn-grows-on-higher-cancer-test-volumes-cm831757,On Aug 11 we issued an updated research report on Salt Lake City UT based molecular diagnostics provider 160 Myriad Genetics Inc MYGN The company currently carries a Zacks Rank 3 Hold For the past three months Myriad has been trading above the broader industry The company
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Grows on Higher Cancer Test Volumes,2017-08-14 14:18:02 +0000,https://finance.yahoo.com/news/myriad-genetics-mygn-grows-higher-141802610.html?.tsrc=rss,"Myriad Genetics (MYGN) rides high on strength in Molecular Diagnostics with significant contributions from GeneSight. Also, hereditary cancer testing continues to witness sequential growth."
MYGN,MYGN:UW,BBG000D9HMX2,Edited Transcript of MYGN earnings conference call or presentation 8-Aug-17 8:30pm GMT,2017-08-12 02:06:09 +0000,https://finance.yahoo.com/news/edited-transcript-mygn-earnings-conference-121832149.html?.tsrc=rss,Q4 2017 Myriad Genetics Inc Earnings Call
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. – Value Analysis (NASDAQ:MYGN) : August 12, 2017",2017-08-12 00:20:45 +0000,http://finance.yahoo.com/r/fd6619c8-9746-3776-beb8-c920196618cf/myriad-genetics-inc-value-analysis-nasdaqmygn-august-12-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Myriad Genetics, Inc. a score of 72. Our analysis is based on comparing Myriad Genetics, Inc. with the following peers – Genomic Health, Inc., Response Genetics, Inc., Foundation Medicine, Inc., Vermillion, Inc., BioMarin Pharmaceutical Inc., Exact Sciences Corporation, Biocept, Inc., Bio-Rad Laboratories, Inc. Class A, Trovagene, Inc. ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Bio-Techne (TECH) Beats Earnings, Revenue Estimates in Q4",2017-08-10 15:40:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/QDIjHGurvT8/bio-techne-tech-beats-earnings-revenue-estimates-in-q4-cm830184,Bio Techne Corporation TECH reported fourth quarter fiscal 2017 adjusted earnings per share considering stock based compensation expenses and related tax impact as regular expenses of 1 02 up 17 2 from the year ago quarter s figure Also earnings surpassed the Zacks Consensus Estimate
MYGN,MYGN:UW,BBG000D9HMX2,Haemonetics Banks on Solid Plasma & Haemonetics Management,2017-08-10 15:40:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/1NGVmae5VGc/haemonetics-banks-on-solid-plasma-haemonetics-management-cm830182,On Aug 9 we issued an updated research report on 160 Haemonetics Corporation 160 HAE a Braintree MA based leading provider of blood management solutions to customers encompassing blood and plasma collectors hospitals and health care providers globally The stock currently carries a
MYGN,MYGN:UW,BBG000D9HMX2,"Chimerix (CMRX) Q2 Loss Narrower than Expected, Revenues Down",2017-08-10 15:40:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/2THUSlu8mOU/chimerix-cmrx-q2-loss-narrower-than-expected-revenues-down-cm830177,Chimerix Inc CMRX reported net loss from continuing operations of 36 cents per share in the second quarter of 2017 compared to net loss of 39 cents a year ago Moreover the reported loss was narrower than the Zacks Consensus Estimate of a loss of 41 cents 160 Revenues In the
MYGN,MYGN:UW,BBG000D9HMX2,CVS Health Grows on Specialty Pharmacy amid Retail Woes,2017-08-10 15:39:47 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/f1hdDafY5PE/cvs-health-grows-on-specialty-pharmacy-amid-retail-woes-cm830172,On Aug 9 we issued an updated research report on Rhode Island based pharmacy retail giant CVS Health Corp CVS which provides integrated offerings across the entire spectrum of pharmacy care Post a better than expected performance in the second quarter CVS Health was observed
MYGN,MYGN:UW,BBG000D9HMX2,CVS Health Grows on Specialty Pharmacy amid Retail Woes,2017-08-10 13:57:01 +0000,https://finance.yahoo.com/news/cvs-health-grows-specialty-pharmacy-135701367.html?.tsrc=rss,CVS Health (CVS) rides on strong PBM selling season. Poor Retail/ LTC business and escalating expenses are drag on the bottom line.
MYGN,MYGN:UW,BBG000D9HMX2,"Chimerix (CMRX) Q2 Loss Narrower than Expected, Revenues Down",2017-08-10 13:55:01 +0000,https://finance.yahoo.com/news/chimerix-cmrx-q2-loss-narrower-135501396.html?.tsrc=rss,Chimerix (CMRX) revenues in Q2 were hurt by reduced reimbursable expenses related to the company&apos;s BARDA developmental contract.
MYGN,MYGN:UW,BBG000D9HMX2,Haemonetics Banks on Solid Plasma & Haemonetics Management,2017-08-10 13:53:01 +0000,https://finance.yahoo.com/news/haemonetics-banks-solid-plasma-haemonetics-135301033.html?.tsrc=rss,"Despite encouraging growth at the Plasma and Haemonetics Management franchises, the underperformance at the BloodCenter franchisee was quite a dampener for Haemonetics (HAE)."
MYGN,MYGN:UW,BBG000D9HMX2,"Bio-Techne (TECH) Beats Earnings, Revenue Estimates in Q4",2017-08-10 13:52:01 +0000,https://finance.yahoo.com/news/bio-techne-tech-beats-earnings-135201629.html?.tsrc=rss,"Bio-Techne (TECH) rides high on strength in all three segments in Q4. Also, the company is focusing on product innovation through research and development."
MYGN,MYGN:UW,BBG000D9HMX2,IHS Markit Score Update: Drop in demand for ETFs holding Myriad Genetics Inc is a negative sign for its shares,2017-08-10 12:06:29 +0000,https://finance.yahoo.com/news/ihs-markit-score-drop-demand-120629247.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Inc (MYGN) Files 10-K for the Fiscal Year Ended on June 30, 2017",2017-08-10 04:48:02 +0000,https://finance.yahoo.com/news/myriad-genetics-inc-mygn-files-044802155.html?.tsrc=rss,"Myriad Genetics Inc (NASDAQ:MYGN) files its latest 10-K with SEC for the fiscal year ended on June 30, 2017."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Beats on Q4 Earnings & Revenues,2017-08-09 15:42:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KNG0Ej2GHoQ/myriad-genetics-mygn-beats-on-q4-earnings-revenues-cm829464,Myriad Genetics Inc MYGN reported adjusted earnings per share EPS of 30 cents in the fourth quarter of fiscal 2017 down 17 year over year However adjusted EPS beat the Zacks Consensus Estimate of 26 cents by 15 4 and surpassed the company s guided range of 26 28 cents
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Beats on Q4 Earnings & Revenues,2017-08-09 13:20:01 +0000,https://finance.yahoo.com/news/myriad-genetics-mygn-beats-q4-132001972.html?.tsrc=rss,"Myriad Genetics (MYGN) rides high on strength in Molecular diagnostics with significant contributions from GeneSight. Also, hereditary cancer testing continues to witness sequential growth."
MYGN,MYGN:UW,BBG000D9HMX2,See what the IHS Markit Score report has to say about Myriad Genetics Inc.,2017-08-09 12:06:31 +0000,https://finance.yahoo.com/news/see-ihs-markit-score-report-120631869.html?.tsrc=rss,Myriad Genetics Inc NASDAQ/NGS:MYGN
MYGN,MYGN:UW,BBG000D9HMX2,Myriad beats Street 4Q forecasts,2017-08-09 02:28:57 +0000,https://finance.yahoo.com/news/myriad-beats-street-4q-forecasts-210947379.html?.tsrc=rss,"The Salt Lake City-based company said it had profit of 19 cents per share. Earnings, adjusted for one-time gains and costs, came to 30 cents per share. The results topped Wall Street expectations. The ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Fiscal Fourth-Quarter 2017 and Fiscal Full-Year 2017 Financial Results,2017-08-08 20:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-reports-fiscal-fourth-200500424.html?.tsrc=rss,Total Revenues of $200.5 Million Up 8 Percent GAAP Diluted EPS was $0.19 and Adjusted EPS of $0.30 Record Hereditary Cancer Demand and 86 Percent of Revenue Under Long-Term Contract Company Issues Fiscal ...
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Q4 Earnings Decline 21%,2017-08-08 16:12:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GdFq6rQisU8/myriad-genetics-inc-q4-earnings-decline-21-20170808-01592,Myriad Genetics Inc. Q4 Earnings Decline 21%
MYGN,MYGN:UW,BBG000D9HMX2,"Investor Network: Myriad Genetics, Inc. to Host Earnings Call",2017-08-08 15:10:00 +0000,https://finance.yahoo.com/news/investor-network-myriad-genetics-inc-151000318.html?.tsrc=rss,"NEW YORK, NY / ACCESSWIRE / August 8, 2017 / Myriad Genetics, Inc. (NASDAQ: MYGN) will be discussing their earnings results in their Q4 Earnings Call to be held on Tuesday, August 08, 2017 at 4:30 PM Eastern ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Q4 17 Earnings Conference Call At 4:30 PM ET,2017-08-08 15:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/M4OLIL6zUJw/myriad-genetics-q4-17-earnings-conference-call-at-430-pm-et-20170808-01368,Myriad Genetics Q4 17 Earnings Conference Call At 4:30 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,Can Myriad Genetics (MYGN) Spring a Surprise in Q4 Earnings?,2017-08-03 14:04:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5QVIyUeqxJY/can-myriad-genetics-mygn-spring-a-surprise-in-q4-earnings-cm826462,Myriad Genetics Inc MYGN is scheduled to report fourth quarter fiscal 2017 results on Aug 8 after the closing bell Last quarter the company posted a positive earnings surprise of 12 5 Moreover Myriad Genetics beat the Zacks Consensus Estimate in two of the trailing four quarters at
MYGN,MYGN:UW,BBG000D9HMX2,Can Myriad Genetics (MYGN) Spring a Surprise in Q4 Earnings?,2017-08-03 12:23:12 +0000,https://finance.yahoo.com/news/myriad-genetics-mygn-spring-surprise-122312383.html?.tsrc=rss,Myriad Genetics (MYGN) is well poised to deliver favorable results in Q4 riding on a diversified portfolio with products like Vectra DA test.
MYGN,MYGN:UW,BBG000D9HMX2,"Notable Monday Option Activity: EPC, MYGN, NYLD",2017-07-31 16:53:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/KFb2Lr5tcPk/notable-monday-option-activity-epc-mygn-nyld-cm824290,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Edgewell Personal Care Co Symbol EPC where a total of 6 034 contracts have traded so far representing approximately 603 400 underlying shares That amounts to about 133 9 of EPC
MYGN,MYGN:UW,BBG000D9HMX2,The scariest part of genetic testing? Not getting an answer at all,2017-07-30 15:23:25 +0000,http://finance.yahoo.com/r/3d06ddc9-4b1d-3c72-b816-8feaf3232abd/the-uncertain-future-of-genetic-testing?utm_source=YPL&yptr=yahoo&.tsrc=rss,"AnneMarie Ciccarella, a fast-talking 57-year-old brunette with a more than a hint of a New York accent, thought she knew a lot about breast cancer. Her mother was diagnosed with the disease in 1987, and several other female relatives also developed it. When doctors found a suspicious lump in one of her breasts that turned…"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad to Announce Fiscal Fourth-Quarter 2017 Financial Results on August 8, 2017",2017-07-28 15:16:52 +0000,https://finance.yahoo.com/news/myriad-announce-fiscal-fourth-quarter-151652070.html?.tsrc=rss,"SALT LAKE CITY, July 28, 2017-- Myriad Genetics, Inc. today announced that it will hold its fiscal fourth-quarter 2017 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bearish Manner : MYGN-US : July 28, 2017",2017-07-28 13:39:23 +0000,http://finance.yahoo.com/r/0c4677da-4fe0-324b-8c7d-fe27ffd49b78/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-mygn-us-july-28-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceGet full CapitalCube analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Myriad Genetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average Bullish ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,The Best Stock in Utah: Myriad Genetics,2017-07-22 12:03:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Nq-r_UGrC2w/the-best-stock-in-utah-myriad-genetics-cm819723,We scoured the nation to identify the best stock in every state Myriad Genetics symbol MYGN is the publicly traded company we picked in Utah The company headquarters is located in Salt Lake City We scoured the nation to identify thebest stock in every state Myriad Genetics
MYGN,MYGN:UW,BBG000D9HMX2,The Best Stock in Utah: Myriad Genetics,2017-07-21 16:50:04 +0000,https://finance.yahoo.com/news/best-stock-utah-myriad-genetics-171008123.html?.tsrc=rss,We analyzed publicly traded companies based in the Beehive State to identify the best stock in Utah to buy now.
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics to Grow with Study Successes, New Alliances",2017-07-10 21:45:33 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/X9aKCKg4Uz4/myriad-genetics-to-grow-with-study-successes-new-alliances-cm814096,On Jul 6 we issued an updated research report on Salt Lake City UT based molecular diagnostics provider Myriad Genetics Inc MYGN The company currently carries a Zacks Rank 3 Hold For the past three months Myriad has been trading above the Zacks categorized 160 Medical
MYGN,MYGN:UW,BBG000D9HMX2,Why Myriad Genetics Stock Rocketed 26.3% Higher in June,2017-07-10 20:46:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uE2BIWOjWpk/why-myriad-genetics-stock-rocketed-263-higher-in-june-cm814056,What happened Shares of Myriad Genetics NASDAQ MYGN a company focused on genetic testing rose more than 26 in June according to data from S amp P Global Market Intelligence So what Investors can credit the gains to a trio of positive announcements First
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics to Grow with Study Successes, New Alliances",2017-07-10 19:31:07 +0000,https://finance.yahoo.com/news/myriad-genetics-grow-study-successes-193107798.html?.tsrc=rss,"On Jul 6, we issued an updated research report on Myriad Genetics, Inc. (MYGN)."
MYGN,MYGN:UW,BBG000D9HMX2,Why Myriad Genetics Stock Rocketed 26.3% Higher in June,2017-07-10 19:11:49 +0000,http://finance.yahoo.com/r/b5b053ef-cd85-3c7f-ac17-6d03f8813316/why-myriad-genetics-stock-rocketed-263-higher-in-j.aspx?yptr=yahoo&.tsrc=rss,Investors bid up the company&apos;s share price after it released a series of positive clinical updates.
MYGN,MYGN:UW,BBG000D9HMX2,JPMorgan Checks In On Myriad Genetics Following 30% Rally,2017-06-29 19:06:07 +0000,https://finance.yahoo.com/news/jpmorgan-checks-myriad-genetics-following-190607219.html?.tsrc=rss,"Myriad Genetics, Inc.'s (NASDAQ: MYGN ) strong run has caught investors attentions, however, JPMorgan analyst Tycho Peterson still doesn't see the stock being able to offset a decline in the hereditary ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7%,2017-06-22 13:23:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xtWxCS5zWzM/myriad-genetics-mygn-catches-eye-stock-moves-up-57-cm806779,Myriad Genetics Inc MYGN was a big mover last session as its shares rose over 5 on the day The move came on solid volume too with far more shares changing hands than in a normal session This continues the recent uptrend for the company as the stock is now up over 25 in the past one
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Catches Eye: Stock Moves Up 5.7%,2017-06-22 12:15:12 +0000,https://finance.yahoo.com/news/myriad-genetics-mygn-catches-eye-121512320.html?.tsrc=rss,"Myriad Genetics, Inc. (MYGN) moved big last session, as its shares rose over 5% on the day."
MYGN,MYGN:UW,BBG000D9HMX2,"Noteworthy Wednesday Option Activity: MYGN, TWTR, WGO",2017-06-21 17:21:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/cpdMBHq0tqM/noteworthy-wednesday-option-activity-mygn-twtr-wgo-cm806351,Looking at options trading activity among components of the Russell 3000 index there is noteworthy activity today in Myriad Genetics Inc Symbol MYGN where a total volume of 5 509 contracts has been traded thus far today a contract volume which is representative of approximately 550
MYGN,MYGN:UW,BBG000D9HMX2,"Virginia C. Drosos, President of Assurex Health, Receives the EY Entrepreneur of the Year 2017 Award in Ohio Valley Region",2017-06-19 11:05:00 +0000,https://finance.yahoo.com/news/virginia-c-drosos-president-assurex-110500375.html?.tsrc=rss,"SALT LAKE CITY, June 19, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Virginia C. Drosos, president of Assurex Health, a wholly-owned ..."
MYGN,MYGN:UW,BBG000D9HMX2,Crescendo Bioscience Announces Results from a Meta-Analysis of Studies with Vectra® DA at the 2017 Annual European Congress of Rheumatology,2017-06-15 11:05:00 +0000,https://finance.yahoo.com/news/crescendo-bioscience-announces-results-meta-110500843.html?.tsrc=rss,"SALT LAKE CITY, June 15, 2017-- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data from a meta-analysis of clinical studies and a registry demonstrating ..."
MYGN,MYGN:UW,BBG000D9HMX2,Crescendo Bioscience Announces Six Studies with Vectra® DA Will Be Presented at the 2017 Annual European Congress of Rheumatology,2017-06-08 11:05:00 +0000,https://finance.yahoo.com/news/crescendo-bioscience-announces-six-studies-110500589.html?.tsrc=rss,"SALT LAKE CITY, June 08, 2017-- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on the use of the Vectra ® DA test will be presented at the European ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive,2017-06-05 19:00:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/s7Z4egKxaCU/myriad-genetics-bracanalysis-cdx-in-olympiad-results-positive-cm798898,Myriad Genetics Inc MYGN a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test This breast cancer BRAC assay successfully identified patients with HER2 metastatic breast cancer in the OlympiAD trial
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics BRACAnalysis CDx in OlympiAD Results Positive,2017-06-05 16:48:04 +0000,https://finance.yahoo.com/news/myriad-genetics-bracanalysis-cdx-olympiad-164804770.html?.tsrc=rss,"Myriad Genetics, Inc. (MYGN), a leading molecular diagnostics and personalized medicine company recently unveiled positive data pertaining to its BRACAnalysis CDx test."
MYGN,MYGN:UW,BBG000D9HMX2,Why Is Myriad Genetics (MYGN) Down 9.6% Since the Last Earnings Report?,2017-06-05 11:00:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/zSKaQvieADk/why-is-myriad-genetics-mygn-down-96-since-the-last-earnings-report-cm798489,A month has gone by since the last earnings report for Myriad Genetics Inc MYGN Shares have lost about 9 6 in that time frame underperforming the market Will the recent negative trend continue leading up to the stock s next earnings release or is it due for a breakout Before we
MYGN,MYGN:UW,BBG000D9HMX2,Why Is Myriad Genetics (MYGN) Down 9.6% Since the Last Earnings Report?,2017-06-05 08:30:08 +0000,https://finance.yahoo.com/news/why-myriad-genetics-mygn-down-083008754.html?.tsrc=rss,Myriad Genetics (MYGN) reported earnings 30 days ago. What&apos;s next for the stock? We take a look at earnings estimates for some clues.
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s BRACAnalysis CDx® Test Identified Patients with Metastatic Breast Cancer Who Benefited from Treatment with Olaparib in Phase 3 OlympiAD Study,2017-06-04 11:30:00 +0000,https://finance.yahoo.com/news/myriad-bracanalysis-cdx-test-identified-113000101.html?.tsrc=rss,"SALT LAKE CITY, June 04, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that its BRACAnalysis CDx ® companion diagnostic test successfully identified ..."
MYGN,MYGN:UW,BBG000D9HMX2,InPlay from Briefing.com,2017-06-02 20:51:11 +0000,https://finance.yahoo.com/news/inplay-briefing-com-115750752.html?.tsrc=rss,InPlay from Briefing.com
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Announces 17 Additional Health Insurance Plans Covering EndoPredict™,2017-06-02 20:05:00 +0000,https://finance.yahoo.com/news/myriad-announces-17-additional-health-200500671.html?.tsrc=rss,"SALT LAKE CITY, June 02, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that multiple new insurance plans have announced positive coverage policies ..."
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : June 2, 2017",2017-06-02 18:21:03 +0000,http://finance.yahoo.com/r/2ef734bc-f3a3-31f3-a8eb-73ad6c7e0e39/etfs-with-exposure-to-myriad-genetics-inc-june-2-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Announces Results from a Large 2,000 Patient Clinical Utility Study of Its myRisk® Hereditary Cancer Test at the 53rd Annual Meeting of ASCO",2017-06-02 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-announces-results-large-110500076.html?.tsrc=rss,"SALT LAKE CITY, June 02, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced results from Study 005, a large 2,000 patient prospective study of the ..."
MYGN,MYGN:UW,BBG000D9HMX2,MYGN Crosses Above Average Analyst Target,2017-06-01 14:32:13 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BDnVjqd_oiI/mygn-crosses-above-average-analyst-target-cm797309,In recent trading shares of Myriad Genetics Inc Symbol MYGN have crossed above the average analyst 12 month target price of 20 18 changing hands for 20 35 share When a stock reaches the target an analyst has set the analyst logically has two ways to react downgrade on valuation
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2017 William Blair Growth Stock Conference,2017-05-31 20:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-2017-william-200500838.html?.tsrc=rss,"SALT LAKE CITY, May 31, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2017 Goldman Sachs Global Healthcare Conference,2017-05-30 20:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-2017-goldman-200500399.html?.tsrc=rss,"SALT LAKE CITY, May 30, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that Mark C. Capone, president and CEO, is scheduled to present at the ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Gets Extended Coverage for Prolaris Test,2017-05-29 14:31:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RWSwysVXegY/myriad-genetics-gets-extended-coverage-for-prolaris-test-cm795850,Molecular diagnostics and personalized medicine major Myriad Genetics Inc MYGN recently received extended Medicare coverage for its Prolasis test According to the company Palmetto GBA a Medicare Administrative Contractor that assesses molecular diagnostic technologies
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Gets Extended Coverage for Prolaris Test,2017-05-29 12:31:12 +0000,https://finance.yahoo.com/news/myriad-genetics-gets-extended-coverage-123112953.html?.tsrc=rss,"Molecular diagnostics and personalized medicine major Myriad Genetics, Inc. (MYGN) recently received extended Medicare coverage for its Prolasis test."
MYGN,MYGN:UW,BBG000D9HMX2,Medicare Coverage of Prolaris® Test Expands with the Addition of Men Diagnosed with Favorable Intermediate Risk Prostate Cancer,2017-05-25 14:38:34 +0000,https://finance.yahoo.com/news/medicare-coverage-prolaris-test-expands-143834872.html?.tsrc=rss,"SALT LAKE CITY, May 25, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that Palmetto GBA, a Medicare Administrative Contractor that assesses ..."
MYGN,MYGN:UW,BBG000D9HMX2,Edited Transcript of MYGN earnings conference call or presentation 2-May-17 8:30pm GMT,2017-05-23 17:00:49 +0000,https://finance.yahoo.com/news/edited-transcript-mygn-earnings-conference-010528734.html?.tsrc=rss,Q3 2017 Myriad Genetics Inc Earnings Call
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : May 22, 2017",2017-05-22 17:55:09 +0000,http://finance.yahoo.com/r/8b37236e-25be-336e-8641-c6f5253eff41/etfs-with-exposure-to-myriad-genetics-inc-may-22-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present Seven Studies at the 2017 American Society of Clinical Oncology Annual Meeting,2017-05-18 11:05:00 +0000,https://finance.yahoo.com/news/myriad-genetics-present-seven-studies-110500653.html?.tsrc=rss,"SALT LAKE CITY, May 18, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it will present results from seven studies at the 2017 American Society ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics’ Prolaris® Test Accurately Predicts the 10-Year Risk of Metastases in Men Treated for Prostate Cancer,2017-05-12 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-prolaris-test-accurately-110500352.html?.tsrc=rss,"SALT LAKE CITY, May 12, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new data demonstrating the utility of the Prolaris ® test to accurately ..."
MYGN,MYGN:UW,BBG000D9HMX2,"ETFs with exposure to Myriad Genetics, Inc. : May 9, 2017",2017-05-09 20:51:12 +0000,http://finance.yahoo.com/r/0fb9b393-148e-31c2-b646-d051fd963e29/etfs-with-exposure-to-myriad-genetics-inc-may-9-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to Myriad Genetics, Inc. Here are 5 ETFs with the largest exposure to MYGN-US. Comparing the performance and risk of Myriad Genetics, Inc. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q3, 2017 By the Numbers : May 8, 2017",2017-05-08 15:13:49 +0000,http://finance.yahoo.com/r/0084bbe8-f6a6-35f5-9714-32401bb42e29/myriad-genetics-inc-mygn-us-earnings-analysis-q3-2017-by-the-numbers-may-8-2017?yptr=yahoo&.tsrc=rss,"Categories:  Yahoo FinanceGet free summary analysis Myriad Genetics, Inc. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of Myriad Genetics, Inc. – BioMarin Pharmaceutical Inc., Exact Sciences Corporation, Bio-Rad Laboratories, Inc. Class A and Abbott Laboratories (BMRN-US, EXAS-US, BIO-US and ABT-US) that have also reported for ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,Don’t Give Up on Buybacks Just Yet,2017-05-08 04:37:09 +0000,http://finance.yahoo.com/r/aa9494c2-cc46-3936-8991-0099d65f2f13/dont-give-up-on-buybacks-just-yet-1494209641?ru=yahoo?mod=yahoo_itp&yptr=yahoo&.tsrc=rss,"Most of the time, buyback stocks don’t pay off the way they used to, but there’s still money to be made in some of them."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present Results from Four Studies at the American Urological Association 2017 Annual Meeting,2017-05-05 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-present-results-four-110500359.html?.tsrc=rss,"SALT LAKE CITY, May 05, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it will present results from four separate prostate cancer studies ..."
MYGN,MYGN:UW,BBG000D9HMX2,Edited Transcript of MYGN earnings conference call or presentation 2-May-17 8:30pm GMT,2017-05-04 19:35:45 +0000,http://finance.yahoo.com/news/edited-transcript-mygn-earnings-conference-010528734.html?.tsrc=rss,Q3 2017 Myriad Genetics Inc Earnings Call
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : May 4, 2017",2017-05-04 12:12:00 +0000,http://finance.yahoo.com/r/fc6a9e34-66d3-3f81-809b-70a768311809/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-mygn-us-may-4-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Myriad Genetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Gainers & Losers Of May 3: PIRS, MYGN, XENT, RXDX, SPPI...",2017-05-03 21:51:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/ycIeLbTKxKc/gainers--losers-of-may-3-pirs-mygn-xent-rxdx-sppi-20170503-02058,"Gainers & Losers Of May 3: PIRS, MYGN, XENT, RXDX, SPPI..."
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Myriad Genetics Rose as Much as 16% This Morning,2017-05-03 19:51:11 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nrz4CkSYWSE/heres-why-myriad-genetics-rose-as-much-as-16-this-morning-cm783673,What happened Shares of genetic testing pioneer Myriad Genetics NASDAQ MYGN received a much needed boost today rising as much as 16 after the company announced fiscal third quarter 2017 financial results The stock has witnessed a 42 decline in the last year although it is
MYGN,MYGN:UW,BBG000D9HMX2,Here&apos;s Why Myriad Genetics Rose as Much as 16% This Morning,2017-05-03 17:40:00 +0000,http://finance.yahoo.com/r/8661d69e-571c-345e-a124-f63f1ba3683f/heres-why-myriad-genetics-rose-as-much-as-16-this.aspx?yptr=yahoo&.tsrc=rss,The genetic-testing pioneer increased its full-year fiscal 2017 revenue guidance and narrowed its EPS range.
MYGN,MYGN:UW,BBG000D9HMX2,"Biotech Movers: Myriad Genetics, Spectrum Pharmaceuticals, Array BioPharma",2017-05-03 14:09:00 +0000,http://finance.yahoo.com/r/d9fdad7d-97e7-373c-ab5a-b92f887243b5/biotech-movers-myriad-genetics-spectrum-pharmaceuticals-array-biopharma.html?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,"Myriad Genetics, Spectrum Pharmaceuticals and Array BioPharma were among the biotech stock movers in early trading on Wednesday."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View",2017-05-03 13:27:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DVRZUo_vKd8/myriad-genetics-mygn-tops-q3-earnings-sales-tweaks-view-cm783396,Myriad Genetics Inc MYGN reported adjusted earnings per share EPS of 27 cents in the third quarter of fiscal 2017 down 34 year over year However adjusted EPS beat the Zacks Consensus Estimate by 12 5 and surpassed the company s guided range of 23 25 cents Including one time
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Tops Q3 Earnings & Sales, Tweaks View",2017-05-03 12:40:12 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-tops-q3-124012392.html?.tsrc=rss,"Myriad Genetics Inc. (MYGN) reported adjusted earnings per share (EPS) of 27 cents in the third quarter of fiscal 2017, down 34% year over year."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad tops Street 3Q forecasts,2017-05-02 21:24:29 +0000,http://finance.yahoo.com/news/myriad-tops-street-3q-forecasts-212429456.html?.tsrc=rss,"The Salt Lake City-based company said it had profit of 6 cents per share. Earnings, adjusted for one-time gains and costs, were 27 cents per share. The results exceeded Wall Street expectations. The average ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics shares jump on earnings beat, outlook",2017-05-02 21:20:56 +0000,http://finance.yahoo.com/r/40ae4707-0e9b-3827-9909-91db055f34ea/Story.aspx?guid=86F79FE0-47A3-4E4D-9346-2AF3DC75B11E&siteid=yhoof2&yptr=yahoo&.tsrc=rss,Myriad Genetics Inc.  shares jumped in the extended session Tuesday after the medical diagnostic test company's quarterly results and outlook topped Wall Street estimates. Myriad Genetics shares ...
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Earnings Retreat 39% In Q3,2017-05-02 19:14:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NV6fqOz_Sjc/myriad-genetics-inc-earnings-retreat-39-in-q3-20170502-01897,Myriad Genetics Inc. Earnings Retreat 39% In Q3
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Increases Annual Revenue Guidance, Narrows Adj. EPS Guidance",2017-05-02 16:38:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6yPviKzxdJQ/myriad-genetics-increases-annual-revenue-guidance-narrows-adj-eps-guidance-20170502-01712,"Myriad Genetics Increases Annual Revenue Guidance, Narrows Adj. EPS Guidance"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Q3 17 Earnings Conference Call At 4:30 PM ET,2017-05-02 15:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8iTlgxdYom4/myriad-genetics-q3-17-earnings-conference-call-at-430-pm-et-20170502-01398,Myriad Genetics Q3 17 Earnings Conference Call At 4:30 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics and Clovis Oncology Sign Agreement for Use of FDA-Approved BRACAnalysis CDx® Test to Identify Patients with Germline BRCA Mutations for Rubraca® (rucaparib) Treatment,2017-04-27 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-clovis-oncology-sign-110500186.html?.tsrc=rss,"SALT LAKE CITY and BOULDER, Colo., April 27, 2017-- Myriad Genetics, Inc. and Clovis Oncology, Inc. today announced a companion diagnostic collaboration to support a post-marketing regulatory commitment ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Pre-Market Most Active for Apr 26, 2017 :  TWTR, MPW, FCAU, NOK, MT, X, CDNS, SIRI, GOGO, INFO, MYGN, HIMX",2017-04-26 12:52:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/y7ihbMtqC10/pre-market-most-active-for-apr-26-2017-twtr-mpw-fcau-nok-mt-x-cdns-siri-gogo-info-mygn-himx-cm779269,The NASDAQ 100 Pre Market Indicator is up 2 81 to 5 551 The total Pre Market volume is currently 21 105 158 shares traded The following are the most active stocks for the pre market session Twitter Inc TWTR is 1 43 at 16 09 with 6 852 042 shares traded
MYGN,MYGN:UW,BBG000D9HMX2,Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings?,2017-04-24 15:08:01 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/H0RVAT68LXo/can-myriad-genetics-mygn-spring-a-surprise-in-q3-earnings-cm777786,Myriad Genetics Inc MYGN is scheduled to report third quarter fiscal 2017 results on May 2 after the closing bell Last quarter the company posted a positive earnings surprise of 8 33 However Myriad Genetics missed the Zacks Consensus Estimate in the trailing four quarters at
MYGN,MYGN:UW,BBG000D9HMX2,Can Myriad Genetics (MYGN) Spring a Surprise in Q3 Earnings?,2017-04-24 12:53:12 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-spring-surprise-125312165.html?.tsrc=rss,"Myriad Genetics, Inc. (MYGN) is scheduled to report third-quarter fiscal 2017 results on May 2, after the closing bell."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Enters Oversold Territory (MYGN),2017-04-20 20:03:50 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Hn8Eo58rOVI/myriad-genetics-enters-oversold-territory-mygn-cm776669,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MYGN,MYGN:UW,BBG000D9HMX2,"Commit To Buy Myriad Genetics At $15, Earn 10.3% Annualized Using Options",2017-04-19 20:03:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8VanrqmYRE8/commit-to-buy-myriad-genetics-at-15-earn-103-annualized-using-options-cm776048,Investors eyeing a purchase of Myriad Genetics Inc Symbol MYGN shares but cautious about paying the going market price of 17 99 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad to Announce Fiscal Third-Quarter 2017 Financial Results on May 2, 2017",2017-04-18 20:05:00 +0000,http://finance.yahoo.com/news/myriad-announce-fiscal-third-quarter-200500746.html?.tsrc=rss,"SALT LAKE CITY, April 18, 2017-- Myriad Genetics, Inc. today announced that it will hold its fiscal third-quarter 2017 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. – Value Analysis (NASDAQ:MYGN) : April 17, 2017",2017-04-17 17:35:41 +0000,http://finance.yahoo.com/r/ffba80ba-0bfa-3ed4-bdac-16d80dd313d4/myriad-genetics-inc-value-analysis-nasdaqmygn-april-17-2017?yptr=yahoo&.tsrc=rss,"Categories:  Fundamental Analysis Yahoo FinanceClick here to see latest analysis Capitalcube gives Myriad Genetics, Inc. a score of 72. Our analysis is based on comparing Myriad Genetics, Inc. with the following peers – Genomic Health, Inc., Response Genetics, Inc., Foundation Medicine, Inc., Vermillion, Inc., BioMarin Pharmaceutical Inc., Exact Sciences Corporation, Biocept, Inc., Bio-Rad Laboratories, Inc. Class A, Trovagene, Inc. ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,Study Finds Wide Gap in Quality of BRCA1/2 Variant Classification Between Myriad Genetics and A Common Public Database,2017-04-17 11:05:00 +0000,http://finance.yahoo.com/news/study-finds-wide-gap-quality-110500566.html?.tsrc=rss,"SALT LAKE CITY, April 17, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that new data comparing BRCA1 and BRCA2 variant classifications between ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bearish Manner : MYGN-US : April 13, 2017",2017-04-13 12:14:41 +0000,http://finance.yahoo.com/r/b1bcea65-416f-3e5e-a6aa-95ff9f422de0/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bearish-manner-mygn-us-april-13-2017?yptr=yahoo&.tsrc=rss,"Categories:  ETFs Yahoo FinanceClick here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Myriad Genetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving ... Read more
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,[$$] FDA clears consumer genetic tests in victory for 23andMe,2017-04-06 17:42:00 +0000,"http://finance.yahoo.com/r/45e1616a-36ca-318a-a719-a4451a755601/ec4eff96-1ae9-11e7-bcac-6d03d067f81f,s01=1.html?ftcamp=traffic/partner/feed_headline/us_yahoo/auddev&yptr=yahoo&.tsrc=rss","Health regulators in the US have for the first time approved a direct-to-consumer genetic test that will inform patients whether they are predisposed to diseases such as Alzheimer's, in a victory for 23andMe, ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics and BeiGene Sign Agreement to Develop Companion Diagnostics for Use with BeiGene’s Novel PARP Inhibitor, BGB-290",2017-04-06 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-beigene-sign-agreement-110500368.html?.tsrc=rss,"SALT LAKE CITY, April 06, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it has entered into a companion diagnostic development collaboration ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Collaborate With BeiGene - Quick Facts,2017-04-06 07:24:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/wMiyj8ZX60M/myriad-genetics-to-collaborate-with-beigene--quick-facts-20170406-00312,Myriad Genetics To Collaborate With BeiGene - Quick Facts
MYGN,MYGN:UW,BBG000D9HMX2,Pivotal Study Results for Myriad’s myPath® Melanoma Test Highlighted In Two Additional Scientific Publications,2017-04-05 11:05:00 +0000,http://finance.yahoo.com/news/pivotal-study-results-myriad-mypath-110500681.html?.tsrc=rss,"SALT LAKE CITY, April 05, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it has published the third clinical validation study and second ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting,2017-03-20 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-announces-five-scientific-110500954.html,"[GlobeNewswire] - SALT LAKE CITY, March 20, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that the company will present five scientific posters at the 2017 American ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Announces Five Scientific Presentations at the 2017 American College of Medical Genetics Annual Clinical Genetics Meeting,2017-03-20 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-announces-five-scientific-110500954.html?.tsrc=rss,"SALT LAKE CITY, March 20, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that the company will present five scientific posters at the 2017 American ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Launches EndoPredict Test in the US,2017-03-14 14:09:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/op389IXPl-w/myriad-genetics-mygn-launches-endopredict-test-in-the-us-cm760371,Myriad Genetics Inc MYGN a leading name in the molecular diagnostics space recently launched the EndoPredict test in the U S for patients with ER HER2 early stage breast cancer 160 EndoPredict is a second generation test primarily for evaluating the 10 year risk of disease
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Launches EndoPredict Test in the US,2017-03-14 11:57:11 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-launches-endopredict-115711093.html,Myriad Genetics (MYGN) Launches EndoPredict Test in the US
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Launches EndoPredict Test in the US,2017-03-14 11:57:11 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-launches-endopredict-115711093.html?.tsrc=rss,"Myriad Genetics, Inc. (MYGN), a leading name in the molecular diagnostics space, recently launched the EndoPredict test in the U.S. for patients with ER+ HER2 -- early-stage breast cancer."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Launches the EndoPredict® Test in the United States for Patients with Breast Cancer,2017-03-13 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-launches-endopredict-test-110500685.html?.tsrc=rss,"SALT LAKE CITY, March 13, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it has launched the EndoPredict ® test in the United States for ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Launches the EndoPredict® Test in the United States for Patients with Breast Cancer,2017-03-13 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-launches-endopredict-test-110500685.html,"[GlobeNewswire] - SALT LAKE CITY, March 13, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that it has launched the EndoPredict ® test in the United States for ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 19:10:46 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nTuQIJvT79A/better-buy-myriad-genetics-inc-vs-opko-health-inc-cm759666,It s been a rough 12 months for Myriad Genetics NASDAQ MYGN and Opko Health NASDAQ OPK Myriad lost nearly half of its market cap during the period while Opko stock is down around 20 Could better days be ahead for these two stocks And which is the better pick
MYGN,MYGN:UW,BBG000D9HMX2,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 17:04:00 +0000,http://www.fool.com/investing/2017/03/11/better-buy-myriad-genetics-inc-vs-opko-health.aspx,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc."
MYGN,MYGN:UW,BBG000D9HMX2,"Better Buy: Myriad Genetics, Inc. vs. Opko Health, Inc.",2017-03-11 17:04:00 +0000,http://finance.yahoo.com/r/f8e98e8e-db13-326d-860f-b09dfdf25936/better-buy-myriad-genetics-inc-vs-opko-health.aspx?yptr=yahoo&.tsrc=rss,Myriad Genetics and Opko Health are two beaten-down healthcare stocks. Which stock wins in a head-to-head match-up?
MYGN,MYGN:UW,BBG000D9HMX2,Why Is Myriad Genetics (MYGN) Up 15.8% Since the Last Earnings Report?,2017-03-10 09:14:37 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/FtuDpJ0iCCw/why-is-myriad-genetics-mygn-up-158-since-the-last-earnings-report-cm758980,A month has gone by since the last earnings report for Myriad Genetics Inc MYGN Shares have added about 15 8 in that time frame outperforming the market Will the recent positive trend continue leading up to the stock s next earnings release or is it due for a pullback Before we
MYGN,MYGN:UW,BBG000D9HMX2,Why Is Myriad Genetics (MYGN) Up 15.8% Since the Last Earnings Report?,2017-03-10 07:27:07 +0000,http://finance.yahoo.com/news/why-myriad-genetics-mygn-15-072707736.html?.tsrc=rss,Myriad Genetics (MYGN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
MYGN,MYGN:UW,BBG000D9HMX2,Why Is Myriad Genetics (MYGN) Up 15.8% Since the Last Earnings Report?,2017-03-10 07:27:07 +0000,http://finance.yahoo.com/news/why-myriad-genetics-mygn-15-072707736.html,Why Is Myriad Genetics (MYGN) Up 15.8% Since the Last Earnings Report?
MYGN,MYGN:UW,BBG000D9HMX2,"3 Big Stock Charts for Thursday: Myriad Genetics, Inc. (MYGN), Wal-Mart Stores Inc (WMT) and Nucor Corporation (NUE)",2017-03-02 21:13:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TfRFhUnvj-M/3-big-stock-charts-for-thursday-myriad-genetics-inc-mygn-wal-mart-stores-inc-wmt-and-nucor-corporation-nue-cm755656,InvestorPlace Stock Market News Stock Advice amp Trading Tips For weeks the market and certain sectors have been operating under uncertainty as doubts over the direction of President Trump s administration were growing After Tuesday night s speech investors are beginning
MYGN,MYGN:UW,BBG000D9HMX2,Bullish and Bearish Reversals in the Market,2017-02-27 19:33:00 +0000,http://finance.yahoo.com/r/33604c9f-f8a8-3c8b-9d26-9b8566c2637e/bullish-and-bearish-reversals-market?puc=yahoo&cm_ven=YAHOO&yptr=yahoo&.tsrc=rss,Finding the stocks that have changed direction.
MYGN,MYGN:UW,BBG000D9HMX2,Bullish and Bearish Reversals in the Market,2017-02-27 19:33:00 +0000,http://realmoney.thestreet.com/articles/02/27/2017/bullish-and-bearish-reversals-market?puc=yahoo&cm_ven=YAHOO,Bullish and Bearish Reversals in the Market
MYGN,MYGN:UW,BBG000D9HMX2,Post Earnings Coverage as Myriad's Q2 Top-line Grew 2%; Topped Estimates,2017-02-27 13:15:00 +0000,http://finance.yahoo.com/news/post-earnings-coverage-myriads-q2-131500689.html?.tsrc=rss,"Upcoming AWS Coverage on INC Research Holdings Post-Earnings Results LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces its post-earnings coverage on Myriad Genetics, Inc. (NASDAQ: ..."
MYGN,MYGN:UW,BBG000D9HMX2,Post Earnings Coverage as Myriad's Q2 Top-line Grew 2%; Topped Estimates,2017-02-27 13:15:00 +0000,http://finance.yahoo.com/news/post-earnings-coverage-myriads-q2-131500689.html,"[Accesswire] - Upcoming AWS Coverage on INC Research Holdings Post-Earnings Results LONDON, UK / ACCESSWIRE / February 27, 2017 / Active Wall St. announces its post-earnings coverage on Myriad Genetics, Inc. (NASDAQ: ..."
MYGN,MYGN:UW,BBG000D9HMX2,7:07 am Myriad Genetics announces publication of new data on the use of the GeneSight Psychotropic test in the journal Clinical Therapeutics,2017-02-23 12:07:00 +0000,http://finance.yahoo.com/news/inplay-briefing-com-055139997.html#mygn,7:07 am Myriad Genetics announces publication of new data on the use of the GeneSight Psychotropic test in the journal Clinical Therapeutics
MYGN,MYGN:UW,BBG000D9HMX2,GeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical Therapeutics,2017-02-23 12:05:00 +0000,http://finance.yahoo.com/news/genesight-psychotropic-test-demonstrated-substantial-120500026.html,"[GlobeNewswire] - SALT LAKE CITY, Feb. 23, 2017-- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on the use of the GeneSight ® Psychotropic test to deliver medication cost ..."
MYGN,MYGN:UW,BBG000D9HMX2,GeneSight® Psychotropic Test Demonstrated Substantial Cost Savings for Payers in New Study Published in Clinical Therapeutics,2017-02-23 12:05:00 +0000,http://finance.yahoo.com/news/genesight-psychotropic-test-demonstrated-substantial-120500026.html?.tsrc=rss,"SALT LAKE CITY, Feb. 23, 2017-- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on the use of the GeneSight ® Psychotropic test to deliver medication cost ..."
MYGN,MYGN:UW,BBG000D9HMX2,Health Care Sector Update for 02/17/2017: MYGN,2017-02-17 14:33:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RfcXq7oG4x4/health-care-sector-update-for-02172017-mygn-cm749513,Top Health care stocks Top Health care stocks JNJ flatJNJ flat PFE 0 5 PFE 0 5 ABT 1 6 ABT 1 6 MRK 0 3 MRK 0 3 AMGN 1 1 AMGN 1 1 Health care shares were mixed in pre market trade Friday Health care shares were mixed in pre market trade Friday In health care stocks
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib",2017-02-17 12:30:00 +0000,http://finance.yahoo.com/news/myriad-bracanalysis-cdx-test-successfully-123000432.html,"[GlobeNewswire] - SALT LAKE CITY, Feb. 17, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new findings from the OlympiAD study that show its BRACAnalysis CDx ® ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad’s BRACAnalysis CDx® Test Successfully Identified Metastatic Breast Cancer Patients with Improved Outcomes from AstraZeneca's PARP Inhibitor, Olaparib",2017-02-17 12:30:00 +0000,http://finance.yahoo.com/news/myriad-bracanalysis-cdx-test-successfully-123000432.html?.tsrc=rss,"SALT LAKE CITY, Feb. 17, 2017-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced new findings from the OlympiAD study that show its BRACAnalysis CDx ® ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer,2017-02-17 12:05:00 +0000,http://finance.yahoo.com/news/myriad-prolaris-test-significantly-improves-120500008.html?.tsrc=rss,"SALT LAKE CITY, Feb. 17, 2017-- Myriad Genetics, Inc., a global leader in personalized medicine, today announced new data demonstrating the utility of the Prolaris ® test to more accurately classify mortality ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s Prolaris® Test Significantly Improves the Risk Classification for One Third of Men Diagnosed with Localized Prostate Cancer,2017-02-17 12:05:00 +0000,http://finance.yahoo.com/news/myriad-prolaris-test-significantly-improves-120500008.html,"[GlobeNewswire] - SALT LAKE CITY, Feb. 17, 2017-- Myriad Genetics, Inc., a global leader in personalized medicine, today announced new data demonstrating the utility of the Prolaris ® test to more accurately classify mortality ..."
MYGN,MYGN:UW,BBG000D9HMX2,"After Hours Most Active for Feb 14, 2017 :  MU, BAC, BSMX, CTSH, INTC, EPD, MYGN, PG, FTR, AAPL, DG, GE",2017-02-14 21:57:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bTrxdPgwTfw/after-hours-most-active-for-feb-14-2017-mu-bac-bsmx-ctsh-intc-epd-mygn-pg-ftr-aapl-dg-ge-cm747945,The NASDAQ 100 After Hours Indicator is up 1 27 to 5 272 34 The total After hours volume is currently 62 051 585 shares traded The following are the most active stocks for the after hours session Micron Technology Inc MU is 0 02 at 23 14 with 6 924 206
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Invitae Stock Jumped as Much as 16.3% This Morning,2017-02-14 18:19:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/quHAypBrnlQ/heres-why-invitae-stock-jumped-as-much-as-163-this-morning-cm747776,What happened Shares of genetic testing company Invitae NYSE NVTA jumped over 16 this morning after announcing full year 2016 earnings and guidance for the current year yesterday afternoon Shares have cooled off a bit since the markets opened but investors should
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Invitae Stock Jumped as Much as 16.3% This Morning,2017-02-14 16:20:29 +0000,http://www.fool.com/investing/2017/02/14/heres-why-invitae-stock-jumped-as-much-as-163-this.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Invitae Stock Jumped as Much as 16.3% This Morning
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Invitae Stock Jumped as Much as 16.3% This Morning,2017-02-14 16:20:29 +0000,http://finance.yahoo.com/r/c007bb9c-18c4-38a6-9685-fd07f4cb1d80/heres-why-invitae-stock-jumped-as-much-as-163-this.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,A strong full-year 2016 earnings report and 2017 guidance demonstrate that Invitae is no longer a concept story.
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : February 14, 2017",2017-02-14 13:31:24 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-mygn-us-february-14-2017/,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : February 14, 2017"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : February 14, 2017",2017-02-14 13:31:24 +0000,http://finance.yahoo.com/r/4207341c-0646-3f28-ab3c-4b0e762fdaa9/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-mygn-us-february-14-2017?yptr=yahoo&.tsrc=rss,"Categories:   ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Myriad Genetics, Inc.. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bullish Closing Price above/below 200 Day Moving ... Read more    
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,MYRIAD GENETICS INC Financials,2017-02-11 18:04:07 +0000,http://finance.yahoo.com/q/is?s=mygn,MYRIAD GENETICS INC Financials
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Join S&P SmallCap 600,2017-02-10 22:47:00 +0000,http://finance.yahoo.com/news/myriad-genetics-join-p-smallcap-224700616.html,"[PR Newswire] - NEW YORK, Feb. 10, 2017 /PRNewswire/ -- Myriad Genetics, Inc. (NASD: MYGN) will replace Inteliquent, Inc. (NASD: IQNT) in the S&P SmallCap 600 after the close on Tuesday, February 14. GTCR LLC has acquired ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Join S&P SmallCap 600,2017-02-10 22:47:00 +0000,http://finance.yahoo.com/news/myriad-genetics-join-p-smallcap-224700616.html?.tsrc=rss,"NEW YORK, Feb. 10, 2017 /PRNewswire/ -- Myriad Genetics, Inc. (NASD: MYGN) will replace Inteliquent, Inc. (NASD: IQNT) in the S&P SmallCap 600 after the close on Tuesday, February 14. GTCR LLC has acquired ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag",2017-02-09 18:18:41 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SdGksvGEgac/myriad-genetics-mygn-q2-impressive-2017-view-a-drag-cm745659,On Feb 8 we issued an updated research report on Salt Lake City UT based molecular diagnostic company Myriad Genetics Inc MYGN The company recently posted stellar second quarter fiscal 2017 results with both earnings and revenues beating the Zacks Consensus Estimate Revenues in
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017",2017-02-09 17:07:36 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-mygn-us-earnings-analysis-q2-2017-by-the-numbers-february-9-2017/,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q2, 2017 By the Numbers : February 9, 2017",2017-02-09 17:07:36 +0000,http://finance.yahoo.com/r/332a8926-50e3-3e3a-abe7-6ee670780bdf/myriad-genetics-inc-mygn-us-earnings-analysis-q2-2017-by-the-numbers-february-9-2017?yptr=yahoo&.tsrc=rss,"Categories:   Yahoo Finance Get free summary analysis Myriad Genetics, Inc. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of Myriad Genetics, Inc. – Abbott Laboratories (ABT-US) that have also reported for this period. Highlights Summary numbers: Revenues of USD 196.50 million, Net Earnings of USD 5.90 million. ... Read more    
<b>(Read more...)</b>"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag",2017-02-09 15:56:03 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-q2-impressive-155603297.html,"Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN): Q2 Impressive, 2017 View a Drag",2017-02-09 15:56:03 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-q2-impressive-155603297.html?.tsrc=rss,"On Feb 8, we issued an updated research report on Salt Lake City, UT-based molecular diagnostic company Myriad Genetics Inc. (MYGN)."
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Myriad Genetics Stock Rose as Much as 16.2% This Morning,2017-02-08 19:19:25 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/VSVHfINkDiQ/heres-why-myriad-genetics-stock-rose-as-much-as-162-this-morning-cm745053,What happened Shares of genetic testing powerhouse Myriad Genetics NASDAQ MYGN rose over 16 this morning following yesterday s release of fiscal second quarter 2017 financial results So what The company achieved the highest level of revenue for any second quarter
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Myriad Genetics Stock Rose as Much as 16.2% This Morning,2017-02-08 17:43:21 +0000,http://finance.yahoo.com/r/b381f722-3a36-35db-be6d-986f4e7d386e/heres-why-myriad-genetics-stock-rose-as-much-as-16.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2&yptr=yahoo&.tsrc=rss,Investors liked what they saw in fiscal second-quarter 2017 financial results.
MYGN,MYGN:UW,BBG000D9HMX2,Here's Why Myriad Genetics Stock Rose as Much as 16.2% This Morning,2017-02-08 17:43:21 +0000,http://www.fool.com/investing/2017/02/08/heres-why-myriad-genetics-stock-rose-as-much-as-16.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Here's Why Myriad Genetics Stock Rose as Much as 16.2% This Morning
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report",2017-02-08 17:42:24 +0000,http://biz.yahoo.com/e/170208/mygn10-q.html,"MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report"
MYGN,MYGN:UW,BBG000D9HMX2,Wednesday’s Biggest Biopharma Movers,2017-02-08 16:35:41 +0000,http://finance.yahoo.com/news/wednesday-biggest-biopharma-movers-163541696.html?.tsrc=rss,"Not that many biotech and pharma companies were on the move Wednesday, but a few of the smaller caps made splash, while one giant company posted a massive loss."
MYGN,MYGN:UW,BBG000D9HMX2,Wednesday’s Biggest Biopharma Movers,2017-02-08 16:35:41 +0000,http://finance.yahoo.com/news/wednesday-biggest-biopharma-movers-163541696.html,Wednesday’s Biggest Biopharma Movers
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Beats on Q2 Earnings, Narrows View",2017-02-08 16:23:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/An-5ePPe2C8/myriad-genetics-mygn-beats-on-q2-earnings-narrows-view-cm744849,Myriad Genetics Inc MYGN reported adjusted earnings per share EPS of 26 cents in the second quarter of fiscal 2017 down 42 2 year over year However adjusted EPS beat the Zacks Consensus Estimate by 8 3 and surpassed the company s guided range of 23 25 cents Including one time items
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: Fairly Valued?,2017-02-08 16:05:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2017/02/08/myriad-genetics-fairly-valued/?mod=yahoobarrons&ru=yahoo,Myriad Genetics: Fairly Valued?
MYGN,MYGN:UW,BBG000D9HMX2,Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments,2017-02-08 15:00:00 +0000,https://www.thestreet.com/story/13994493/1/gilead-sciences-galena-biopharma-lead-biotech-movers.html?puc=yahoo&cm_ven=YAHOO,Gilead Sciences Leads Biotech Movers -- Plus Jim Cramer's Comments
MYGN,MYGN:UW,BBG000D9HMX2,"Stocks Open Lower; Myriad, Microchip, Inphi Climb",2017-02-08 14:47:37 +0000,http://www.investors.com/market-trend/stock-market-today/dollar-stock-futures-trade-mixed-myriad-microchip-inphi-climb/,"Stocks Open Lower; Myriad, Microchip, Inphi Climb"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Beats on Q2 Earnings, Narrows View",2017-02-08 14:21:02 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-beats-q2-142102735.html,"Myriad Genetics (MYGN) Beats on Q2 Earnings, Narrows View"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics upgraded by Ladenburg Thalmann,2017-02-08 11:48:07 +0000,http://finance.yahoo.com/q/ud?s=MYGN,Myriad Genetics upgraded by Ladenburg Thalmann
MYGN,MYGN:UW,BBG000D9HMX2,Edited Transcript of MYGN earnings conference call or presentation 7-Feb-17 9:30pm GMT,2017-02-08 05:46:35 +0000,http://finance.yahoo.com/news/edited-transcript-mygn-earnings-conference-054635694.html,Edited Transcript of MYGN earnings conference call or presentation 7-Feb-17 9:30pm GMT
MYGN,MYGN:UW,BBG000D9HMX2,Myriad beats Street 2Q forecasts,2017-02-07 21:52:50 +0000,http://sg.finance.yahoo.com/news/myriad-beats-street-2q-forecasts-215250360.html,Myriad beats Street 2Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina",2017-02-07 21:16:58 +0000,http://biz.yahoo.com/e/170207/mygn8-k.html,"MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Fiscal Second-Quarter 2017 Financial Results,2017-02-07 21:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-reports-fiscal-second-210500693.html,[GlobeNewswire] - Second-Quarter 2017 Total Revenues of $196.5 Million Second-Quarter 2017 GAAP Diluted EPS of $0.09 and Adjusted EPS of $0.26 Company Updates Fiscal Year 2017 Guidance and Issues Fiscal Third-Quarter 2017 ...
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Profit Drops 48% In Q2,2017-02-07 16:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/I5gAjKne1N4/myriad-genetics-inc-profit-drops-48-in-q2-20170207-01545,Myriad Genetics Inc. Profit Drops 48% In Q2
MYGN,MYGN:UW,BBG000D9HMX2,The Math Shows IYH Can Go To $170,2017-02-07 15:18:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/sWWqBf8xFoE/the-math-shows-iyh-can-go-to-170-cm744102,Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel we have compared the trading price of each holding against the average analyst 12 month forward target price and computed the weighted average implied analyst target price for the ETF itself For the
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Q2 17 Earnings Conference Call At 4:30 PM ET,2017-02-07 15:02:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/c3n0taRZhMo/myriad-genetics-q2-17-earnings-conference-call-at-430-pm-et-20170207-01342,Myriad Genetics Q2 17 Earnings Conference Call At 4:30 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,Q2 2017 Myriad Genetics Inc Earnings Release - After Market Close,2017-02-07 12:07:05 +0000,http://biz.yahoo.com/research/earncal/20170207.html?t=mygn,Q2 2017 Myriad Genetics Inc Earnings Release - After Market Close
MYGN,MYGN:UW,BBG000D9HMX2,Implied Volatility Surging for Myriad Genetics (MYGN) Stock Options,2017-01-25 15:35:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/stoxDZtjKNk/implied-volatility-surging-for-myriad-genetics-mygn-stock-options-cm737903,Investors in shares of Myriad Genetics Inc MYGN need to pay close attention to the stock based on moves in the options market lately That is because the Callwhich expires onFeb 17 2017 for the 47strike price had some of the highest implied volatility of all equity options
MYGN,MYGN:UW,BBG000D9HMX2,Implied Volatility Surging for Myriad Genetics (MYGN) Stock Options,2017-01-25 13:50:01 +0000,http://finance.yahoo.com/news/implied-volatility-surging-myriad-genetics-135001761.html,Implied Volatility Surging for Myriad Genetics (MYGN) Stock Options
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad to Announce Fiscal Second-Quarter 2017 Financial Results on February 7, 2017",2017-01-24 21:05:00 +0000,http://finance.yahoo.com/news/myriad-announce-fiscal-second-quarter-210500928.html,"[GlobeNewswire] - SALT LAKE CITY, Jan. 24, 2017-- Myriad Genetics, Inc. today announced that it will hold its fiscal second-quarter 2017 sales and earnings conference call with investors and analysts at 4:30 p.m. ET on ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?,2017-01-23 16:05:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/UV38BD1_5bo/myriad-genetics-mygn-q2-earnings-whats-in-the-cards-cm736607,Myriad Genetics Inc MYGN is expected to report second quarter fiscal 2017 results on Feb 7 after the closing bell Last quarter the company posted a negative earnings surprise of 11 54 However its earnings outpaced the Zacks Consensus Estimate in two of the last four quarters with
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?,2017-01-23 13:50:01 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-q2-earnings-135001630.html,Myriad Genetics (MYGN) Q2 Earnings: What's in the Cards?
MYGN,MYGN:UW,BBG000D9HMX2,Casualty List Has Done Well; Here's the Latest,2017-01-19 00:00:27 +0000,http://finance.yahoo.com/news/casualty-list-done-well-heres-000027538.html,Casualty List Has Done Well; Here's the Latest
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Stock Dropped 61% in 2016",2017-01-14 22:57:15 +0000,http://www.fool.com/investing/2017/01/13/why-myriad-genetics-inc-stock-dropped-61-in-2016.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Myriad Genetics, Inc. Stock Dropped 61% in 2016"
MYGN,MYGN:UW,BBG000D9HMX2,Why Exact Sciences' Stock Could Go Much Higher,2017-01-14 17:10:07 +0000,http://www.fool.com/investing/2017/01/13/why-exact-sciences-stock-could-go-much-higher.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Why Exact Sciences' Stock Could Go Much Higher
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Stock Dropped 61% in 2016",2017-01-14 00:36:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MXlctm_l2ls/why-myriad-genetics-inc-stock-dropped-61-in-2016-cm733554,Image source Getty Images What happened Shares of Myriad Genetics Inc NASDAQ MYGN a DNA diagnostics specialist dropped 61 4 last year according to 160 data from S amp P Global Market Intelligence 160 Efforts to offset hereditary cancer testing segment
MYGN,MYGN:UW,BBG000D9HMX2,Why Exact Sciences' Stock Could Go Much Higher,2017-01-13 18:38:17 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6wTzln-cYKk/why-exact-sciences-stock-could-go-much-higher-cm733402,Exact Sciences NASDAQ EXAS announced preliminary fourth quarter and full year 2016 financial results on Sunday Those numbers were so impressive that the molecular diagnostics company s stock soared more than 20 On Thursday Exact Sciences CEO Kevin Conroy spoke at the J P
MYGN,MYGN:UW,BBG000D9HMX2,Better Buy: Myriad Genetics vs. Exact Sciences,2017-01-09 15:52:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PiZIxbjHN78/better-buy-myriad-genetics-vs-exact-sciences-cm731000,Human understanding of genetics is changing the world and two companies in the forefront of that momentous change are Myriad Genetics NASDAQ MYGN and Exact Sciences NASDAQ EXAS However the molecular diagnostics companies stocks have taken quite different trajectories
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Present At JP Morgan Conference; Webcast At 6:00 PM ET,2017-01-09 15:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_LGoySm8XKc/myriad-genetics-to-present-at-jp-morgan-conference-webcast-at-600-pm-et-20170109-00876,Myriad Genetics To Present At JP Morgan Conference; Webcast At 6:00 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,Better Buy: Myriad Genetics vs. Exact Sciences,2017-01-09 14:56:12 +0000,http://www.fool.com/investing/2017/01/09/better-buy-myriad-genetics-inc-vs-exact-sciences.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Myriad Genetics vs. Exact Sciences
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: Evidence Street Reviews EndoPredict Test,2017-01-06 14:40:53 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NAH1keVCtHI/myriad-genetics-evidence-street-reviews-endopredict-test-cm730235,Myriad Genetics Inc MYGN a leading molecular diagnostics and personalized medicine company recently announced that Blue Cross Blue Shield Association s technical assessment provider Evidence Street has reviewed its EndoPredict assay It is Myriad Genetics second generation multi gene
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: Evidence Street Reviews EndoPredict Test,2017-01-06 12:57:12 +0000,http://finance.yahoo.com/news/myriad-genetics-evidence-street-reviews-125712897.html,Myriad Genetics: Evidence Street Reviews EndoPredict Test
MYGN,MYGN:UW,BBG000D9HMX2,The EndoPredict® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield Affiliate Plans,2017-01-06 12:55:08 +0000,http://www.publicnow.com/view/393D204F23D730FE6B266664C49128B3208F8D68,"[at noodls] - SALT LAKE CITY, Jan. 06, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in personalized medicine, today announced that multiple Blue Cross Blue Shield (BCBS) affiliate plans ..."
MYGN,MYGN:UW,BBG000D9HMX2,The EndoPredict® Test Receives Positive Coverage Decisions from Multiple Blue Cross Blue Shield Affiliate Plans,2017-01-06 12:05:00 +0000,http://finance.yahoo.com/news/endopredict-test-receives-positive-coverage-120500874.html,"[GlobeNewswire] - SALT LAKE CITY, Jan. 06, 2017-- Myriad Genetics, Inc., a global leader in personalized medicine, today announced that multiple Blue Cross Blue Shield affiliate plans have issued positive coverage determinations ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : January 5, 2017",2017-01-05 13:14:06 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-mygn-us-january-5-2017/,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : January 5, 2017"
MYGN,MYGN:UW,BBG000D9HMX2,EndoPredict® Reviewed by Blue Cross Blue Shield Association's Evidence Street,2017-01-05 12:34:06 +0000,http://www.publicnow.com/view/460ED0196523FC9B6B72EA32A31ED4C7063B679E,"[at noodls] - SALT LAKE CITY, Jan. 05, 2017 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in personalized medicine, today announced that Evidence Street has reviewed EndoPredict, Myriad's ..."
MYGN,MYGN:UW,BBG000D9HMX2,EndoPredict® Reviewed by Blue Cross Blue Shield Association’s Evidence Street,2017-01-05 12:05:00 +0000,http://finance.yahoo.com/news/endopredict-reviewed-blue-cross-blue-120500420.html,"[GlobeNewswire] - SALT LAKE CITY, Jan. 05, 2017-- Myriad Genetics, Inc., a global leader in personalized medicine, today announced that Evidence Street has reviewed EndoPredict ®, Myriad’ s second-generation test to predict ..."
MYGN,MYGN:UW,BBG000D9HMX2,Industrial Companies Showing Good Potential for 2017,2017-01-04 22:49:46 +0000,http://finance.yahoo.com/news/industrial-companies-showing-good-potential-224946684.html,Industrial Companies Showing Good Potential for 2017
MYGN,MYGN:UW,BBG000D9HMX2,Gurus and Insiders Invest in Industrial and Medical Companies,2016-12-30 22:16:00 +0000,http://finance.yahoo.com/news/gurus-insiders-invest-industrial-medical-221600592.html,Gurus and Insiders Invest in Industrial and Medical Companies
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan",2016-12-28 16:34:00 +0000,http://biz.yahoo.com/e/161228/mygn8-k.html,"MYRIAD GENETICS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an Obligation under an Off-Balan"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' Unit Releases Favorable Data on Vectra DA,2016-12-28 15:01:52 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/rfFDUov-4zY/myriad-genetics-unit-releases-favorable-data-on-vectra-da-cm726776,Myriad Genetics Inc s MYGN subsidiary Crescendo Bioscience continues to make development with its Vectra DA assay After last week s announcement of its contract with United Rheumatology on this assay it has once again come up with favorable data on the use of Vectra DA to predict
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' Unit Releases Favorable Data on Vectra DA,2016-12-28 13:02:01 +0000,http://finance.yahoo.com/news/myriad-genetics-unit-releases-favorable-130201382.html,Myriad Genetics' Unit Releases Favorable Data on Vectra DA
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2017 JP Morgan Healthcare Conference,2016-12-28 12:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-present-2017-jp-120500451.html,"[GlobeNewswire] - SALT LAKE CITY, Dec. 28, 2016-- Myriad Genetics, Inc. announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 2017 JP Morgan Healthcare Conference at 6:00 ..."
MYGN,MYGN:UW,BBG000D9HMX2,Medicare Decisions For Myriad Present A Mixed Bag,2016-12-27 15:07:35 +0000,http://finance.yahoo.com/news/medicare-decisions-myriad-present-mixed-150735367.html,Medicare Decisions For Myriad Present A Mixed Bag
MYGN,MYGN:UW,BBG000D9HMX2,Positive Clinical Utility Results of Crescendo's Vectra® DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology,2016-12-27 12:32:06 +0000,http://www.publicnow.com/view/23250D1ADB7871CBBD5656E40385A296DC3104BF,"[at noodls] - SALT LAKE CITY, Dec. 27, 2016 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that new data on the use of Vectra DA test to predict ..."
MYGN,MYGN:UW,BBG000D9HMX2,Positive Clinical Utility Results of Crescendo’s Vectra® DA Test for Rheumatoid Arthritis Published in the Journal Arthritis & Rheumatology,2016-12-27 12:05:00 +0000,http://finance.yahoo.com/news/positive-clinical-utility-results-crescendo-120500666.html,"[GlobeNewswire] - SALT LAKE CITY, Dec. 27, 2016-- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that new data on the use of Vectra ® DA test to predict treatment response in patients ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Health Care Sector Update for 12/23/2016: MYGN,DPRX,SBBP,TARO",2016-12-23 21:17:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/z2HUSWsZGbY/health-care-sector-update-for-12232016-mygndprxsbbptaro-cm725875,Top Health Care StocksTop Health Care Stocks JNJ 0 32 JNJ 0 32 PFE 0 17 PFE 0 17 MRK 0 27 MRK 0 27 ABT 0 30 ABT 0 30 AMGN 0 59 AMGN 0 59 Health care stocks outpaced all other sectors by a considerable margin today with the NYSE Health Care Index holding on to a 0 5 advance
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: United Rheumatology Selects Vectra DA Test,2016-12-23 14:00:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6aqkwpA-IX4/myriad-genetics-united-rheumatology-selects-vectra-da-test-cm725600,Myriad Genetics Inc s MYGN subsidiary Crescendo Bioscience recently announced that its Vectra DA assay has been added by United Rheumatology to its clinical practice guidelines for adults with rheumatoid arthritis RA United Rheumatology is a leading professional organization
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: United Rheumatology Selects Vectra DA Test,2016-12-23 12:32:12 +0000,http://finance.yahoo.com/news/myriad-genetics-united-rheumatology-selects-123212987.html,Myriad Genetics: United Rheumatology Selects Vectra DA Test
MYGN,MYGN:UW,BBG000D9HMX2,United Rheumatology Issues Clinical Practice Guidelines and Recommends the Vectra® DA Test for Adults with Rheumatoid Arthritis,2016-12-22 20:38:05 +0000,http://www.publicnow.com/view/5484B1CDA99769BBF017DEE85D7E7CD4005D5305,"[at noodls] - SALT LAKE CITY, Dec. 22, 2016 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that United Rheumatology, a leading professional ..."
MYGN,MYGN:UW,BBG000D9HMX2,The 1 Stock I'd Buy Right Now,2016-12-20 13:57:39 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IQKid_Uj6rU/the-1-stock-id-buy-right-now-cm723756,Image source Getty Images Investors would be forgiven for not noticing it but the genetic testing industry has been quietly undergoing a radical transformation in recent years Gone are the days when a single company could monopolize a cancer screening test by patenting genes To
MYGN,MYGN:UW,BBG000D9HMX2,The 1 Stock I'd Buy Right Now,2016-12-20 12:20:38 +0000,http://www.fool.com/investing/2016/12/20/the-1-stock-id-buy-right-now.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,The 1 Stock I'd Buy Right Now
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. – Value Analysis (NASDAQ:MYGN) : December 19, 2016",2016-12-19 15:51:53 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-value-analysis-nasdaqmygn-december-19-2016/,"Myriad Genetics, Inc. – Value Analysis (NASDAQ:MYGN) : December 19, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : December 16, 2016",2016-12-16 12:09:04 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-breached-its-50-day-moving-average-in-a-bullish-manner-mygn-us-december-16-2016/,"Myriad Genetics, Inc. breached its 50 day moving average in a Bullish Manner : MYGN-US : December 16, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,​EXCLUSIVE: Employee No. 1 departing Assurex Health,2016-12-13 15:25:06 +0000,http://www.bizjournals.com/cincinnati/news/2016/12/13/exclusive-employee-no-1-departing-assurex-health.html?ana=yahoo,​EXCLUSIVE: Employee No. 1 departing Assurex Health
MYGN,MYGN:UW,BBG000D9HMX2,Will Endopredict Win Myriad's (MYGN) Genomic Testing War?,2016-12-12 15:01:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/vNjM3_MG7LY/will-endopredict-win-myriads-mygn-genomic-testing-war-cm719971,Renowned molecular diagnostics and personalized medicine company Myriad Genetics Inc MYGN released six favorable study results on its EndoPredict test a second generation multigene test that predicts the risk of breast cancer recurrence 160 The results led by scientists at the Institute
MYGN,MYGN:UW,BBG000D9HMX2,Will Endopredict Win Myriad's (MYGN) Genomic Testing War?,2016-12-12 12:24:12 +0000,http://finance.yahoo.com/news/endopredict-win-myriads-mygn-genomic-122412330.html,Will Endopredict Win Myriad's (MYGN) Genomic Testing War?
MYGN,MYGN:UW,BBG000D9HMX2,The EndoPredict® Test Significantly Outperforms the First-Generation Test in Predicting the Risk of Node-Negative and Node-Positive Breast Cancer Recurrence,2016-12-09 12:05:00 +0000,http://finance.yahoo.com/news/endopredict-test-significantly-outperforms-first-120500539.html,"[GlobeNewswire] - SALT LAKE CITY, Dec. 09, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced results of a large head-to-head study comparing the efficacy of six tests ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad: EndoPredict Test Outperforms In Predicting Breast Cancer Recurrence Risk,2016-12-09 07:26:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/XLi0YCQXchk/myriad-endopredict-test-outperforms-in-predicting-breast-cancer-recurrence-risk-20161209-00146,Myriad: EndoPredict Test Outperforms In Predicting Breast Cancer Recurrence Risk
MYGN,MYGN:UW,BBG000D9HMX2,This ETF Holds Stocks Insiders Want to Own,2016-12-07 15:58:51 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/SndGnxLTi08/this-etf-holds-stocks-insiders-want-to-own-cm717929,A look at the weighted underlying holdings of the First Trust Small Cap Value AlphaDEX Fund FYT shows an impressive 12 6 of holdings on a weighted basis have experienced insider buying within the past six months Abercrombie amp Fitch Co Symbol ANF which makes up 0 96 of
MYGN,MYGN:UW,BBG000D9HMX2,"Notable Monday Option Activity: MYGN, MCRN, AIRM",2016-12-06 21:21:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/E4bX0RBIuyc/notable-monday-option-activity-mygn-mcrn-airm-cm717435,Among the underlying components of the Russell 3000 index we saw noteworthy options trading volume today in Myriad Genetics Inc Symbol MYGN where a total of 23 087 contracts have traded so far representing approximately 2 3 million underlying shares That amounts to about 184 6 of MYGN
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of",2016-12-02 16:53:53 +0000,http://biz.yahoo.com/e/161202/mygn8-k.html,"MYRIAD GENETICS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of"
MYGN,MYGN:UW,BBG000D9HMX2,"Has the Smart Money Unearthed a Hidden Gem in Myriad Genetics, Inc. (MYGN)?",2016-12-01 21:26:28 +0000,http://www.insidermonkey.com/blog/has-the-smart-money-unearthed-a-hidden-gem-in-myriad-genetics-inc-mygn-493371/,"Has the Smart Money Unearthed a Hidden Gem in Myriad Genetics, Inc. (MYGN)?"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Will Present Results from Six Breast Cancer Studies at SABCS,2016-11-28 12:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-present-results-six-120500616.html,"[GlobeNewswire] - SALT LAKE CITY, Nov. 28, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that the Company will present six breast cancer studies at the 2016 San ..."
MYGN,MYGN:UW,BBG000D9HMX2,"How This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) & Other Stocks Performed in Q3?",2016-11-18 17:06:03 +0000,http://www.insidermonkey.com/blog/how-this-funds-investments-in-northstar-asset-management-nsam-conmed-corporation-cnmd-other-stocks-performed-in-q3-486718/,"How This Fund’s Investments in NorthStar Asset Management (NSAM), CONMED Corporation (CNMD) & Other Stocks Performed in Q3?"
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements an",2016-11-14 22:44:24 +0000,http://biz.yahoo.com/e/161114/mygn8-k_a.html,"MYRIAD GENETICS INC Files SEC form 8-K/A, Completion of Acquisition or Disposition of Assets, Financial Statements an"
MYGN,MYGN:UW,BBG000D9HMX2,Crescendo Bioscience Announces Four Studies with Vectra® DA Will Be Presented at the American College of Rheumatology 2016 Annual Meeting,2016-11-12 21:30:00 +0000,http://finance.yahoo.com/news/crescendo-bioscience-announces-four-studies-213000633.html,"[GlobeNewswire] - SALT LAKE CITY, Nov. 12, 2016-- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that four poster presentations on Vectra ® DA will be featured at the American ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Will Seek Japanese Regulatory Approval for BRACAnalysis CDx®,2016-11-07 12:14:10 +0000,http://www.publicnow.com/view/5D6603243E528BD1BA42CFEC20BBB9A3791D2CD1,"[at noodls] - SALT LAKE CITY, Nov. 07, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it will submit its BRACAnalysis ..."
MYGN,MYGN:UW,BBG000D9HMX2,Time to Get Greedy With This Under-the-Radar Stock,2016-11-04 14:51:20 +0000,http://www.fool.com/investing/2016/11/03/time-to-get-greedy-with-this-under-the-radar-stock.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Time to Get Greedy With This Under-the-Radar Stock
MYGN,MYGN:UW,BBG000D9HMX2,The GeneSight® Precision Medicine Test Drives Significant Medication Cost Savings in Patients with Generalized Anxiety Disorder,2016-11-04 11:16:06 +0000,http://www.publicnow.com/view/E6E24E806D72DA266EF7F50B22B5CA1C8A90DB6B,"[at noodls] - SALT LAKE CITY, Nov. 04, 2016 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that a poster featuring the GeneSight test will be presented ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Genomic Health, Inc.: Almost at Breakeven",2016-11-04 02:23:06 +0000,http://www.fool.com/investing/2016/11/03/genomic-health-inc-almost-at-breakeven.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Genomic Health, Inc.: Almost at Breakeven"
MYGN,MYGN:UW,BBG000D9HMX2,"Genomic Health, Inc.: Almost at Breakeven",2016-11-03 22:08:55 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JO1Y8rNr23g/genomic-health-inc-almost-at-breakeven-cm703684,Image source Getty Images Genomic Health NASDAQ GHDX released third quarter earnings on Thursday afternoon reducing its loss and laying out a path to breakeven in the fourth quarter Genomic Health results The raw numbers
MYGN,MYGN:UW,BBG000D9HMX2,Time to Get Greedy With This Under-the-Radar Stock,2016-11-03 16:09:29 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/J9BPoOw-75o/time-to-get-greedy-with-this-under-the-radar-stock-cm703335,Image source Getty Images Earlier this year the White House announced a moonshot effort in personalized medicine powered by advances and continued investments in genomics which have been nothing short of amazing Consider that the cost of DNA sequencing has
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Posts 1Q Loss Vs Profit a Year Ago (MYGN),2016-11-03 06:45:00 +0000,http://www.investopedia.com/news/myriad-genetics-1q-results-below-street-mygn/?partner=YahooSA,Myriad Posts 1Q Loss Vs Profit a Year Ago (MYGN)
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Got Knocked Down Today",2016-11-02 20:08:57 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/8KkGu4uSuZg/why-myriad-genetics-inc-got-knocked-down-today-cm702774,Image source Getty Images What happened Myriad Genetics NASDAQ MYGN is down more than 15 at 2 09 p m EDT after announcing earnings for its first fiscal quarter after the bell yesterday So what Revenue fell 3 year over year as sales of its hereditary cancer
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Got Knocked Down Today",2016-11-02 18:34:56 +0000,http://www.fool.com/investing/2016/11/02/why-myriad-genetics-inc-got-knocked-down-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Myriad Genetics, Inc. Got Knocked Down Today"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics is Now Oversold (MYGN),2016-11-02 18:07:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5F9zIC4HZrM/myriad-genetics-is-now-oversold-mygn-cm702656,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Earnings Miss, Revenues Top in Q1",2016-11-02 17:08:23 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/DwF5kPk455k/myriad-genetics-mygn-earnings-miss-revenues-top-in-q1-cm702583,Myriad Genetics Inc MYGN reported adjusted earnings per share EPS of 23 cents in the first quarter of fiscal 2017 down 43 9 year over year Adjusted EPS also missed the Zacks Consensus Estimate by 11 5 and lagged the company s guided range of 25 27 cents Including one time items
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report",2016-11-02 15:54:23 +0000,http://biz.yahoo.com/e/161102/mygn10-q.html,"MYRIAD GENETICS INC Files SEC form 10-Q, Quarterly Report"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Earnings Miss, Revenues Top in Q1",2016-11-02 15:10:03 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-earnings-miss-151003489.html,"Myriad Genetics (MYGN) Earnings Miss, Revenues Top in Q1"
MYGN,MYGN:UW,BBG000D9HMX2,Edited Transcript of MYGN earnings conference call or presentation 1-Nov-16 8:30pm GMT,2016-11-02 01:55:51 +0000,http://finance.yahoo.com/news/edited-transcript-mygn-earnings-conference-015551284.html,Edited Transcript of MYGN earnings conference call or presentation 1-Nov-16 8:30pm GMT
MYGN,MYGN:UW,BBG000D9HMX2,Myriad reports 1Q loss,2016-11-01 21:03:48 +0000,http://sg.finance.yahoo.com/news/myriad-reports-1q-loss-210348784.html,Myriad reports 1Q loss
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina",2016-11-01 20:16:20 +0000,http://biz.yahoo.com/e/161101/mygn8-k.html,"MYRIAD GENETICS INC Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD Disclosure, Fina"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Fiscal First-Quarter 2017 Financial Results,2016-11-01 20:16:10 +0000,http://www.publicnow.com/view/22038DF6CDE5380F93EFC29AD74446D5DF6BE856,[at noodls] - Total Revenues of $177.5 Million Adjusted EPS of $0.23 and Diluted EPS of ($0.02) Company Maintains Fiscal Year 2017 Financial Guidance and Issues Fiscal Second-Quarter 2017 Financial Guidance SALT LAKE ...
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Profit Retreats 46% In Q1,2016-11-01 16:23:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dRyrweLv6gg/myriad-genetics-inc-profit-retreats-46-in-q1-20161101-00872,Myriad Genetics Inc. Profit Retreats 46% In Q1
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Q1 17 Earnings Conference Call At 4:30 PM ET,2016-11-01 15:01:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/A3LWpm6aJTM/myriad-genetics-q1-17-earnings-conference-call-at-430-pm-et-20161101-00568,Myriad Genetics Q1 17 Earnings Conference Call At 4:30 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,Q1 2017 Myriad Genetics Inc Earnings Release - After Market Close,2016-11-01 11:07:06 +0000,http://biz.yahoo.com/research/earncal/20161101.html?t=mygn,Q1 2017 Myriad Genetics Inc Earnings Release - After Market Close
MYGN,MYGN:UW,BBG000D9HMX2,The Myriad myPath® Melanoma Test Effectively Diagnosed Patients in the Largest Outcomes-Based Study for a Melanoma Diagnostic,2016-10-27 11:16:15 +0000,http://www.publicnow.com/view/B4EE9427530ED9E3F85FC232C98B85FAF0B4B36F,"[at noodls] - SALT LAKE CITY, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present two new studies at the ..."
MYGN,MYGN:UW,BBG000D9HMX2,Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing,2016-10-26 14:20:10 +0000,http://finance.yahoo.com/news/exclusive-myriad-genetics-discusses-growing-142010720.html,Exclusive: Myriad Genetics Discusses The Growing Market In Genetic Testing
MYGN,MYGN:UW,BBG000D9HMX2,Myriad's BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib,2016-10-26 11:35:06 +0000,http://www.publicnow.com/view/05BB6AB63B7CB844CB4491607E69CDD8FC803180,"[at noodls] - SALT LAKE CITY, Oct. 26, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that its BRACAnalysis CDx test accurately ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s BRACAnalysis CDx® Test Identifies Patients with Ovarian Cancer Who Would Benefit from Second-Line Maintenance Treatment with Olaparib,2016-10-26 11:15:00 +0000,http://finance.yahoo.com/news/myriad-bracanalysis-cdx-test-identifies-111500722.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 26, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that its BRACAnalysis CDx ® test accurately identified patients who may ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad RBM Announces an Agreement with Sanofi to Measure Predictive Cardiovascular Biomarkers in Patients with Diabetes,2016-10-25 11:11:01 +0000,http://www.publicnow.com/view/BA0C8DEED24F0BA573C113988C1E14CA216471CC,"[at noodls] - SALT LAKE CITY, Oct. 25, 2016 (GLOBE NEWSWIRE) -- Myriad RBM, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), today announced that it will work with Sanofi, a global and diversified healthcare ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Q1 Earnings: A Beat in the Cards?,2016-10-24 16:28:05 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/xEH3dDY0fbE/myriad-genetics-mygn-q1-earnings-a-beat-in-the-cards-cm697245,Myriad Genetics Inc MYGN is scheduled to report first quarter fiscal 2017 results on Nov 1 after the closing bell Last quarter the company posted a negative earnings surprise of 5 26 However Myriad s earnings outpaced the Zacks Consensus Estimate in three of the last four quarters
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) Q1 Earnings: A Beat in the Cards?,2016-10-24 14:01:02 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-q1-earnings-140102780.html,Myriad Genetics (MYGN) Q1 Earnings: A Beat in the Cards?
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nation's Largest Network of Community Oncologists,2016-10-21 13:39:03 +0000,http://www.publicnow.com/view/F1A79F93054E50AA0EC2F7D97C33920F2B538615,"[at noodls] - SALT LAKE CITY, Oct. 21, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Forms Relationship with ION Solutions to Deliver Quality Hereditary Cancer Tests and Services to the Nation’s Largest Network of Community Oncologists,2016-10-21 13:29:40 +0000,http://finance.yahoo.com/news/myriad-genetics-inc-forms-relationship-132940570.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 21, 2016-- Myriad Genetics, Inc., a global leader in personalized medicine, and ION Solutions, a part of AmerisourceBergen, and the largest physician services organization specializing ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Announce Fiscal First-Quarter 2017 Financial Results on November 1,2016-10-20 11:28:05 +0000,http://www.publicnow.com/view/31C6739E1D050C37EF49AD2FDAAC1638B416557C,"[at noodls] - SALT LAKE CITY, Oct. 20, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it will hold its fiscal first-quarter 2017 sales and earnings conference call with investors and ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Teams Up with Project BioEYES to Advance STEM Education in Utah,2016-10-18 11:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-teams-project-bioeyes-110500712.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 18, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, announced today that more than 40 of its employees are volunteering to support Project ..."
MYGN,MYGN:UW,BBG000D9HMX2,​George Church-founded gene sequencing firm Veritas Genetics raises $30M,2016-10-17 17:20:11 +0000,http://www.bizjournals.com/boston/blog/bioflash/2016/10/george-church-founded-gene-sequencing-firm.html?ana=yahoo,​George Church-founded gene sequencing firm Veritas Genetics raises $30M
MYGN,MYGN:UW,BBG000D9HMX2,Benjamin Graham's 'Intelligent Investing' Approach: 3 Stocks To Buy,2016-10-17 14:10:00 +0000,http://www.forbes.com/sites/investor/2016/10/17/benjamin-grahams-intelligent-investing-approach-3-stocks-to-buy/?utm_source=yahoo&utm_medium=partner&utm_campaign=yahootix&partner=yahootix,Benjamin Graham's 'Intelligent Investing' Approach: 3 Stocks To Buy
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Will Present New Data on Its Variant Classification Program at the ASHG Annual Meeting,2016-10-17 11:05:00 +0000,http://finance.yahoo.com/news/myriad-present-data-variant-classification-110500580.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 17, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced it will present four new studies at the American Society of Human Genetics ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Encouraging myChoice HRD Data,2016-10-12 14:42:48 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/-w1bgcAGKGo/myriad-genetics-reports-encouraging-mychoice-hrd-data-cm692373,Molecular diagnostics major Myriad Genetics Inc MYGN recently announced that its myChoice HRD test recognized more patients with ovarian cancer who may benefit from treatment with niraparib The myChoice HRD test was assessed in the NOVA study NCT01847274 of nirarapib an orally active
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Encouraging myChoice HRD Data,2016-10-12 13:13:01 +0000,http://finance.yahoo.com/news/myriad-genetics-reports-encouraging-mychoice-131301140.html,Myriad Genetics Reports Encouraging myChoice HRD Data
MYGN,MYGN:UW,BBG000D9HMX2,"Why Bristol-Myers Squibb, Myriad Genetics, and Twilio Slumped Today",2016-10-11 00:18:38 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GONeZ2f2tyE/why-bristol-myers-squibb-myriad-genetics-and-twilio-slumped-today-cm691376,The stock market performed well on Monday with the Dow climbing 88 points and other major market benchmarks posting similar gains of roughly half a percent Many investors were pleased with the continued advances in the crude oil market where prices approached the 52 per barrel level
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Got Crushed Today",2016-10-10 23:18:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YlD6vfGL2vo/why-myriad-genetics-inc-got-crushed-today-cm691362,Image source Getty Images What happened Myriad Genetics NASDAQ MYGN fell 11 6 today after Tesaro NASDAQ TSRO presented data at the European Society for Medical Oncology 160 that suggest Myriad Genetics companion diagnostic test might not be necessary
MYGN,MYGN:UW,BBG000D9HMX2,"Why Bristol-Myers Squibb, Myriad Genetics, and Twilio Slumped Today",2016-10-10 22:42:00 +0000,http://www.fool.com/investing/2016/10/10/why-bristol-myers-squibb-myriad-genetics-and-twili.aspx?source=yahoo-2-news&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2-news,"Why Bristol-Myers Squibb, Myriad Genetics, and Twilio Slumped Today"
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Got Crushed Today",2016-10-10 21:43:20 +0000,http://www.fool.com/investing/2016/10/10/why-myriad-genetics-inc-got-crushed-today.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why Myriad Genetics, Inc. Got Crushed Today"
MYGN,MYGN:UW,BBG000D9HMX2,Will Insiders Be Tempted To Buy More MYGN At The New 52-Week Low?,2016-10-10 21:17:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/auxENbM8ZUs/will-insiders-be-tempted-to-buy-more-mygn-at-the-new-52-week-low-cm691313,In trading on Monday shares of Myriad Genetics Inc Symbol MYGN touched a new 52 week low of 18 58 share That s a 27 66 share price drop or 59 82 decline from the 52 week high of 46 24 set back on 11 04 2015 Large percentage drops always require that the stock post even
MYGN,MYGN:UW,BBG000D9HMX2,"Here’s Why Bristol-Myers Squibb Co (BMY), Telefonica Brasil SA (ADR) (VIV) and Three Other Stocks Plunged on Monday",2016-10-10 17:52:44 +0000,http://www.insidermonkey.com/blog/heres-why-bristol-myers-squibb-co-bmy-telefonica-brasil-sa-adr-viv-and-three-other-stocks-plunged-on-monday-480027/,"Here’s Why Bristol-Myers Squibb Co (BMY), Telefonica Brasil SA (ADR) (VIV) and Three Other Stocks Plunged on Monday"
MYGN,MYGN:UW,BBG000D9HMX2,Tesaro's ovarian cancer drug benefits all patients in study,2016-10-08 08:33:45 +0000,http://finance.yahoo.com/news/tesaros-ovarian-cancer-drug-benefits-083345531.html,Tesaro's ovarian cancer drug benefits all patients in study
MYGN,MYGN:UW,BBG000D9HMX2,Myriad's myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib,2016-10-08 06:53:10 +0000,http://www.publicnow.com/view/923C89A0004F6C1A73AF2A4B0E7BAFB3B5FB644F,"[at noodls] - SALT LAKE CITY, Oct. 08, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that its myChoice HRD test identified ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad’s myChoice® HRD Test Identifies Patients with Ovarian Cancer Who May Benefit from Treatment with Niraparib,2016-10-08 06:30:00 +0000,http://finance.yahoo.com/news/myriad-mychoice-hrd-test-identifies-063000155.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 08, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that its myChoice ® HRD test identified more than double the number of ..."
MYGN,MYGN:UW,BBG000D9HMX2,Tesaro Cancer Drug’s Results May Challenge Need for Myriad Test,2016-10-08 06:15:00 +0000,http://www.bloomberg.com/news/articles/2016-10-08/tesaro-cancer-drug-s-results-may-challenge-need-for-myriad-test?cmpid=yhoo.headline,Tesaro Cancer Drug’s Results May Challenge Need for Myriad Test
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Announces Four Poster Presentations at the 2016 European Society for Medical Oncology (ESMO) Annual Meeting,2016-10-07 06:15:00 +0000,http://finance.yahoo.com/news/myriad-announces-four-poster-presentations-061500451.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 07, 2016-- Myriad Genetics, Inc., a leader in molecular diagnostics and personalized medicine, today announced that four poster presentations will be featured at the 2016 European ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Gets Selected for Hereditary Cancer Testing,2016-10-06 15:46:36 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/InSqDHv02ho/myriad-genetics-gets-selected-for-hereditary-cancer-testing-cm689729,Molecular diagnostic major Myriad Genetics Inc MYGN recently announced that the US Oncology Network has selected its subsidiary Myriad Genetic Laboratories as its preferred provider for hereditary cancer testing The U S Oncology Network is one of the country s largest networks of
MYGN,MYGN:UW,BBG000D9HMX2,"ETF’s with exposure to Myriad Genetics, Inc. : October 6, 2016",2016-10-06 14:04:20 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-myriad-genetics-inc-october-6-2016/,"ETF’s with exposure to Myriad Genetics, Inc. : October 6, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Gets Selected for Hereditary Cancer Testing,2016-10-06 13:54:01 +0000,http://finance.yahoo.com/news/myriad-genetics-gets-selected-hereditary-135401358.html,Myriad Genetics Gets Selected for Hereditary Cancer Testing
MYGN,MYGN:UW,BBG000D9HMX2,"Commit To Buy Myriad Genetics At $17, Earn 10.4% Annualized Using Options",2016-10-05 17:43:21 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/5YZ7JE4DICk/commit-to-buy-myriad-genetics-at-17-earn-104-annualized-using-options-cm689288,Investors considering a purchase of Myriad Genetics Inc Symbol MYGN stock but cautious about paying the going market price of 21 14 share might benefit from considering selling puts among the alternative strategies at their disposal One interesting put contract in particular is the
MYGN,MYGN:UW,BBG000D9HMX2,The US Oncology Network Selects Myriad Genetics as Preferred Provider for Hereditary Cancer Testing,2016-10-04 11:28:05 +0000,http://www.publicnow.com/view/DBE0B91D30B944130649F00A3DEED4D258BF2155,"[at noodls] - THE WOODLANDS, Texas and SALT LAKE CITY, Oct. 04, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) and The US Oncology Network (The Network) announced today that The Network has selected Myriad ..."
MYGN,MYGN:UW,BBG000D9HMX2,CORRECTED: Crescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual Meeting,2016-10-03 20:20:53 +0000,http://finance.yahoo.com/news/corrected-crescendo-bioscience-announces-four-202053004.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 03, 2016-- Note: the titles and abstract numbers have been corrected. Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that four poster presentations ..."
MYGN,MYGN:UW,BBG000D9HMX2,Crescendo Bioscience Announces Four Poster Presentations at the American College of Rheumatology 2016 Annual Meeting,2016-10-03 11:05:00 +0000,http://finance.yahoo.com/news/crescendo-bioscience-announces-four-poster-110500412.html,"[GlobeNewswire] - SALT LAKE CITY, Oct. 03, 2016-- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc., today announced that four poster presentations on Vectra ® DA will be featured at the American ..."
MYGN,MYGN:UW,BBG000D9HMX2,3 Signs Invitae's Best Days Are Ahead,2016-09-29 20:38:28 +0000,http://www.fool.com/investing/2016/09/28/3-signs-invitaes-best-days-are-ahead.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,3 Signs Invitae's Best Days Are Ahead
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Appoints Chip Parkinson as EVP for Reimbursement Strategy,2016-09-29 11:20:07 +0000,http://www.publicnow.com/view/49268A4167515410B76C1250F067D97218A3D12C,"[at noodls] - SALT LAKE CITY, Sept. 29, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that Chip Parkinson will join the company in the newly created position of executive vice president ..."
MYGN,MYGN:UW,BBG000D9HMX2,3 Signs Invitae's Best Days Are Ahead,2016-09-28 22:22:26 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/gdM9J2h_4ns/3-signs-invitaes-best-days-are-ahead-cm686256,Image source Getty Images Investors are probably more familiar with Myriad Genetics NASDAQ MYGN than with its tiny and relatively new competitor Invitae NYSE NVTA and for good reason The former is valued at 1 5 billion and realized 754 million in revenue in 2015
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present myRisk Data at Seattle Conference,2016-09-28 12:21:20 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/BHbh50ZYpMw/myriad-genetics-to-present-myrisk-data-at-seattle-conference-cm685750,Molecular diagnostics and personalized medicine major Myriad Genetics Inc MYGN is gearing up to present 160 three new myRisk Hereditary Cancer studies with favorable data at the National Society of Genetic Counselors Annual Education Conference beginning today through Oct 1 2016
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present myRisk Data at Seattle Conference,2016-09-28 09:53:09 +0000,http://finance.yahoo.com/news/myriad-genetics-present-myrisk-data-095309253.html,Myriad Genetics to Present myRisk Data at Seattle Conference
MYGN,MYGN:UW,BBG000D9HMX2,Top-Rated Stock Picks and Popular Stories on Nasdaq.com: September 18 - 24,2016-09-27 15:13:22 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/PtrabIGVJIY/top-rated-stock-picks-and-popular-stories-on-nasdaqcom-september-18-24-cm685331,"Welcome to the latest installment of community stock picks and overview of some of the most-read stories of the week. We're taking a look at stocks chosen by members of the Nasdaq.com community from September 18 - 24.   Bullish Stocks: Here's What You Said:    Myriad Genetics ( MYGN ): Great pipeline, great market"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Present New myRisk Hereditary Cancer Data Further Demonstrating the Benefits of Gene Panel Testing,2016-09-26 11:19:05 +0000,http://www.publicnow.com/view/3AE8ED599039D22770AF7F6A6B04487D2E1B0E73,"[at noodls] - SALT LAKE CITY, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced it will present three new studies at ..."
MYGN,MYGN:UW,BBG000D9HMX2,5 Stocks to Trade for Big Breakout Gains,2016-09-23 12:36:00 +0000,https://www.thestreet.com/story/13750029/1/5-stocks-to-trade-for-big-breakout-gains.html?puc=yahoo&cm_ven=YAHOO,5 Stocks to Trade for Big Breakout Gains
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Becomes Oversold (MYGN),2016-09-21 17:20:19 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V46_XYae2Lc/myriad-genetics-becomes-oversold-mygn-cm682724,Legendary investor Warren Buffett advises to be fearful when others are greedy and be greedy when others are fearful One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index or RSI which measures momentum on
MYGN,MYGN:UW,BBG000D9HMX2,"ETF’s with exposure to Myriad Genetics, Inc. : September 21, 2016",2016-09-21 14:51:10 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-myriad-genetics-inc-september-21-2016/,"ETF’s with exposure to Myriad Genetics, Inc. : September 21, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Shouldn't Overlook This Tiny Competitor,2016-09-17 19:20:35 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/uS4Wz0soLCw/myriad-genetics-shouldnt-overlook-this-tiny-competitor-cm680958,Image source Getty Images When it rains it pours That s especially true for investors of genetic testing leader Myriad Genetics NASDAQ MYGN who have had to stomach year to date losses of 51 Much of the decline was catalyzed by the company s fiscal fourth quarter
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Shouldn't Overlook This Tiny Competitor,2016-09-17 18:11:54 +0000,http://www.fool.com/investing/2016/09/17/myriad-genetics-shouldnt-overlook-this-tiny-compet.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Myriad Genetics Shouldn't Overlook This Tiny Competitor
MYGN,MYGN:UW,BBG000D9HMX2,Major Averages Close Mixed Following Recent Volatility - U.S. Commentary,2016-09-14 16:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_fCWxaxgMuk/major-averages-close-mixed-following-recent-volatility--us-commentary-20160914-00995,Major Averages Close Mixed Following Recent Volatility - U.S. Commentary
MYGN,MYGN:UW,BBG000D9HMX2,Major Averages Close Mixed Following Recent Volatility - U.S. Commentary,2016-09-14 16:22:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/_duuIn8OZLg/major-averages-close-mixed-following-recent-volatility--us-commentary-20160914-00994,Major Averages Close Mixed Following Recent Volatility - U.S. Commentary
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' TruCulture Study Results Favorable,2016-09-12 15:35:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dvzmbdfMUdY/myriad-genetics-truculture-study-results-favorable-cm677942,Personalized medicine major Myriad Genetics Inc s MYGN wholly owned subsidiary Myriad RBM Inc recently announced the release of landmark research work from the Milieu Interieur Project by Institut Pasteur The publication affirmed the ability to perform standardized transcriptome
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' TruCulture Study Results Favorable,2016-09-12 13:28:01 +0000,http://finance.yahoo.com/news/myriad-genetics-truculture-study-results-132801228.html,Myriad Genetics' TruCulture Study Results Favorable
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Present At Morgan Stanley Conference; Webcast At 9:20 AM ET,2016-09-12 08:20:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/V0B-nYkaibU/myriad-genetics-to-present-at-morgan-stanley-conference-webcast-at-920-am-et-20160912-00409,Myriad Genetics To Present At Morgan Stanley Conference; Webcast At 9:20 AM ET
MYGN,MYGN:UW,BBG000D9HMX2,"ETF’s with exposure to Myriad Genetics, Inc. : September 9, 2016",2016-09-09 15:07:22 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-myriad-genetics-inc-september-9-2016/,"ETF’s with exposure to Myriad Genetics, Inc. : September 9, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,"Here's Why Myriad Genetics, Inc. Had Its DNA Scrambled, Causing Its Stock to Fall 34% in August",2016-09-07 19:18:43 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/frKtysaTojQ/heres-why-myriad-genetics-inc-had-its-dna-scrambled-causing-its-stock-to-fall-34-in-august-cm675819,Image source Getty Images What happened Myriad Genetics NASDAQ MYGN a personalized medicine company that provides an array of molecular diagnostic tests had its DNA scrambled in August with shares of the company plunging 34 during the month according to data
MYGN,MYGN:UW,BBG000D9HMX2,"Here's Why Myriad Genetics, Inc. Had Its DNA Scrambled, Causing Its Stock to Fall 34% in August",2016-09-07 17:51:37 +0000,http://www.fool.com/investing/2016/09/07/heres-why-myriad-genetics-inc-had-its-dna-scramble.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Here's Why Myriad Genetics, Inc. Had Its DNA Scrambled, Causing Its Stock to Fall 34% in August"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad RBM's TruCulture® and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur,2016-09-07 11:19:06 +0000,http://www.publicnow.com/view/D50296A0322657D8D234EFA024C5E437CFA51FFF,"[at noodls] - SALT LAKE CITY, Sept. 07, 2016 (GLOBE NEWSWIRE) -- Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that researchers ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad RBM’s TruCulture® and Gene Expression Profiling Characterizes Immune Responses in Landmark Study Led by Institut Pasteur,2016-09-07 11:05:00 +0000,http://finance.yahoo.com/news/myriad-rbm-truculture-gene-expression-110500108.html,"[GlobeNewswire] - SALT LAKE CITY, Sept. 07, 2016-- Myriad RBM, Inc., a wholly owned subsidiary of Myriad Genetics, Inc. a global leader in personalized medicine, announced today that researchers from the Institut Pasteur ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Adds Assurex Health, Grows in Neuroscience",2016-09-06 22:17:12 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/fJ6DQJM5RGk/myriad-genetics-adds-assurex-health-grows-in-neuroscience-cm675236,Molecular diagnostics and personalized medicine major Myriad Genetics Inc MYGN recently closed the company s earlier announced acquisition of Assurex Health the Mason Ohio based personalized medicine company and a popular name in the field of genetic testing for psychotropic
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Adds Assurex Health, Grows in Neuroscience",2016-09-06 20:36:08 +0000,http://finance.yahoo.com/news/myriad-genetics-adds-assurex-health-203608516.html,"Myriad Genetics Adds Assurex Health, Grows in Neuroscience"
MYGN,MYGN:UW,BBG000D9HMX2,Danaher Corporation (DHR) Buys Cepheid (CPHD): Who’s Next?,2016-09-06 20:18:59 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/0JixjToEpDo/danaher-corporation-dhr-buys-cepheid-cphd-whos-next-cm675191,InvestorPlace InvestorPlace Stock Market News Stock Advice amp Trading Tips Danaher Corporation 160 NYSE DHR announced today 160 that it 160 is buying genetic testing company Cepheid 160 NASDAQ CPHD 160 in a deal
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Fina",2016-09-01 20:25:35 +0000,http://biz.yahoo.com/e/160901/mygn8-k.html,"MYRIAD GENETICS INC Files SEC form 8-K, Completion of Acquisition or Disposition of Assets, Creation of a Direct Fina"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Completes Acquisition of Assurex Health,2016-09-01 20:13:03 +0000,http://www.publicnow.com/view/677693BFADF0CC16B81FB2D65A8F08201A04E63C,"[at noodls] - SALT LAKE CITY, Sept. 01, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) a global leader in personalized medicine, announced today that it has completed its acquisition of Assurex Health ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the 2016 Morgan Stanley Global Healthcare Conference,2016-08-30 20:05:00 +0000,http://finance.yahoo.com/news/myriad-genetics-present-2016-morgan-200500768.html,"[GlobeNewswire] - SALT LAKE CITY, Aug. 30, 2016-- Myriad Genetics, Inc. announced today that Mark C. Capone, president and CEO, Myriad Genetics, is scheduled to present at the 2016 Morgan Stanley Global Healthcare Conference ..."
MYGN,MYGN:UW,BBG000D9HMX2,Assurex Health CEO Gina Drosos to speak at Bizwomen Breakfast,2016-08-30 13:20:12 +0000,http://www.bizjournals.com/cincinnati/news/2016/08/30/assurex-health-ceo-gina-drosos-to-speak-at.html?ana=yahoo,Assurex Health CEO Gina Drosos to speak at Bizwomen Breakfast
MYGN,MYGN:UW,BBG000D9HMX2,"ETF’s with exposure to Myriad Genetics, Inc. : August 29, 2016",2016-08-29 15:50:12 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-myriad-genetics-inc-august-29-2016/,"ETF’s with exposure to Myriad Genetics, Inc. : August 29, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,EXCLUSIVE: Assurex Health buyer has a Cincinnati connection (Video),2016-08-24 19:03:59 +0000,http://www.bizjournals.com/cincinnati/news/2016/08/16/exclusive-assurex-health-buyer-has-acincinnati.html?ana=yahoo,EXCLUSIVE: Assurex Health buyer has a Cincinnati connection (Video)
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: 2016 By the Numbers : August 23, 2016",2016-08-23 13:08:48 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-mygn-us-earnings-analysis-2016-by-the-numbers-august-23-2016/,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: 2016 By the Numbers : August 23, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?,2016-08-19 13:49:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bHG5RzhoAxI/weakness-seen-in-myriad-genetics-mygn-estimates-should-you-stay-away-cm667700,"Similar to wise buying decisions, exiting certain underperformers at the right time helps maximize portfolio returns. Selling off losers can be difficult, but if both the share price and estimates are falling, it could be time to"
MYGN,MYGN:UW,BBG000D9HMX2,Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?,2016-08-19 11:59:11 +0000,http://finance.yahoo.com/news/weakness-seen-myriad-genetics-mygn-115911277.html,Weakness Seen in Myriad Genetics (MYGN) Estimates: Should You Stay Away?
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin",2016-08-16 14:38:34 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3oQs68JBsoQ/myriad-genetics-q4-hit-by-low-test-revenues-gross-margin-cm665855,"On Aug 16, we issued an updated research report on Salt Lake City, UT based molecular diagnostics provider, Myriad Genetics, Inc.MYGN . The company currently carries a Zacks Rank #4 (Sell). Myriad ended fiscal 2016 on a disappointing note,"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin",2016-08-16 12:38:12 +0000,http://finance.yahoo.com/news/myriad-genetics-q4-hit-low-123812718.html,"Myriad Genetics: Q4 Hit by Low Test Revenues, Gross Margin"
MYGN,MYGN:UW,BBG000D9HMX2,Better Buy: Exact Sciences Corporation vs. Myriad Genetics,2016-08-15 15:35:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/MIgvzrOdgsY/better-buy-exact-sciences-corporation-vs-myriad-genetics-cm665298,Image source  Getty Images.  Two molecular diagnostics companies  One is profitable. The other isn't. One saw its bottom line grow year over year in the most recent quarter. The other saw a
MYGN,MYGN:UW,BBG000D9HMX2,"ETF’s with exposure to Myriad Genetics, Inc. : August 15, 2016",2016-08-15 14:37:36 +0000,http://www.capitalcube.com/blog/index.php/etfs-with-exposure-to-myriad-genetics-inc-august-15-2016/,"ETF’s with exposure to Myriad Genetics, Inc. : August 15, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,Better Buy: Exact Sciences Corporation vs. Myriad Genetics,2016-08-15 14:07:00 +0000,http://www.fool.com/investing/2016/08/15/better-buy-exact-sciences-corporation-vs-myriad-ge.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,Better Buy: Exact Sciences Corporation vs. Myriad Genetics
MYGN,MYGN:UW,BBG000D9HMX2,Top 6 Companies That Destroyed Shareholders Last Week,2016-08-14 14:05:26 +0000,http://247wallst.com/investing/2016/08/14/top-6-companies-that-destroyed-shareholders-last-week/,Top 6 Companies That Destroyed Shareholders Last Week
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) in Focus: Stock Up 5.6% in Session,2016-08-12 14:53:54 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/qFdtq6ywrTM/myriad-genetics-mygn-in-focus-stock-up-56-in-session-cm664609,"Myriad Genetics, Inc.MYGN was a big mover last session, as the company saw its shares rise around 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q4, 2016 By the Numbers : August 12, 2016",2016-08-12 14:27:01 +0000,http://www.capitalcube.com/blog/index.php/myriad-genetics-inc-mygn-us-earnings-analysis-q4-2016-by-the-numbers-august-12-2016/,"Myriad Genetics, Inc. :MYGN-US: Earnings Analysis: Q4, 2016 By the Numbers : August 12, 2016"
MYGN,MYGN:UW,BBG000D9HMX2,CEO: Most Assurex employees will keep jobs after sale,2016-08-12 13:57:25 +0000,http://www.bizjournals.com/cincinnati/news/2016/08/04/ceo-most-assurex-employees-will-keep-jobs-after.html?ana=yahoo,CEO: Most Assurex employees will keep jobs after sale
MYGN,MYGN:UW,BBG000D9HMX2,Assurex Health sold for $225M (Video),2016-08-12 13:55:20 +0000,http://www.bizjournals.com/cincinnati/news/2016/08/03/assurex-health-sold-for-225m.html?ana=yahoo,Assurex Health sold for $225M (Video)
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics (MYGN) in Focus: Stock Up 5.6% in Session,2016-08-12 12:35:12 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-focus-stock-123512163.html,Myriad Genetics (MYGN) in Focus: Stock Up 5.6% in Session
MYGN,MYGN:UW,BBG000D9HMX2,Why the value of Assurex Health's buyer just plummeted,2016-08-11 20:55:59 +0000,http://www.bizjournals.com/cincinnati/news/2016/08/11/why-the-value-of-assurex-healths-buyer-just.html?ana=yahoo,Why the value of Assurex Health's buyer just plummeted
MYGN,MYGN:UW,BBG000D9HMX2,Will Myriad Genetics (MYGN) Stock React to Price Target Cut at Jefferies?,2016-08-11 18:46:00 +0000,https://www.thestreet.com/story/13673171/1/will-myriad-genetics-mygn-stock-react-to-price-target-cut-at-jefferies.html?puc=yahoo&cm_ven=YAHOO,Will Myriad Genetics (MYGN) Stock React to Price Target Cut at Jefferies?
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Has Downside in Its DNA,2016-08-11 18:01:00 +0000,http://realmoney.thestreet.com/articles/08/11/2016/myriad-genetics-has-downside-its-dna?puc=yahoo&cm_ven=YAHOO,Myriad Genetics Has Downside in Its DNA
MYGN,MYGN:UW,BBG000D9HMX2,"Why SunPower, Myriad Genetics, and Cliffs Natural Resources Slumped Today",2016-08-10 23:53:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/bvqFUZnUZ2g/why-sunpower-myriad-genetics-and-cliffs-natural-resources-slumped-today-cm663756,"Image source  Cliffs Natural Resources.  Wednesday wasn't a strong day for the stock market, with major market benchmarks falling as much as almost half a percentage point on the day. Weakness in the"
MYGN,MYGN:UW,BBG000D9HMX2,"Why SunPower, Myriad Genetics, and Cliffs Natural Resources Slumped Today",2016-08-10 21:52:00 +0000,http://www.fool.com/investing/2016/08/10/why-sunpower-myriad-genetics-and-cliffs-natural-re.aspx?source=yahoo-2&utm_campaign=article&utm_medium=feed&utm_source=yahoo-2,"Why SunPower, Myriad Genetics, and Cliffs Natural Resources Slumped Today"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Stock Craters As Competition Surprises Wall Street,2016-08-10 20:48:11 +0000,http://www.investors.com/news/technology/myriad-genetics-stock-craters-as-competition-surprises-wall-street/,Myriad Genetics Stock Craters As Competition Surprises Wall Street
MYGN,MYGN:UW,BBG000D9HMX2,"Health Care Sector Update for 08/10/2016: WGBS,VSAR,MYGN",2016-08-10 20:25:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/JzLsM4hqTeY/health-care-sector-update-for-08102016-wgbsvsarmygn-cm663678,"Top Health Care Stocks JNJ 0.02% PFE +0.04% MRK 0.60% ABT +0.21% AMGN 0.30% Health care stocks fell today, with the NYSE Health Care Index descending about 0.5% while shares of health care companies in the S&P 500 were"
MYGN,MYGN:UW,BBG000D9HMX2,Mid-Afternoon Market Update: Dow Falls 50 Points; Myriad Genetics Shares Decline Following Downbeat Results,2016-08-10 19:59:32 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9e9bVizgbVI/mid-afternoon-market-update-dow-falls-50-points-myriad-genetics-shares-decline-following-downbeat-results-cm663677,"Toward the end of trading Wednesday, the Dow traded down 0.29 percent to 18,478.68 while the NASDAQ declined 0.51 percent to 5,199.06. The S&P also fell, dropping 0.40 percent to 2,173.05.  Leading and Lagging"
MYGN,MYGN:UW,BBG000D9HMX2,"Wednesday Sector Laggards: Defense, Biotechnology Stocks",2016-08-10 19:49:24 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/HHJyWiC7Wk8/wednesday-sector-laggards-defense-biotechnology-stocks-cm663636,"In trading on Wednesday, defense shares were relative laggards, down on the day by about 3.9%. Helping drag down the group were shares of Orbital ATK ( OA ), down about 21% and shares of Aerojet Rocketdyne Holdings ("
MYGN,MYGN:UW,BBG000D9HMX2,"Wednesday's ETF Movers: GDX, FBT",2016-08-10 19:49:07 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/RNY3QqUpDHk/wednesdays-etf-movers-gdx-fbt-cm663633,"In trading on Wednesday, the Gold Miners ETF ( GDX ) is outperforming other ETFs, up about 2% on the day. Components of that ETF showing particular strength include shares of Tahoe Resources ( TAHO ), up about 7.6%"
MYGN,MYGN:UW,BBG000D9HMX2,"Why Myriad Genetics, Inc. Got Pummeled Today",2016-08-10 18:51:58 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/6tnwVxSPl7o/why-myriad-genetics-inc-got-pummeled-today-cm663585,Image source  Getty Images.  What  Myriad Genetics (NASDAQ  MYGN) is down 33% at 12 35 p.m. EDT after releasing disappointing fiscal fourth quarter earnings and guidance for fiscal year 2017 after
MYGN,MYGN:UW,BBG000D9HMX2,5 Big Stocks to Add to Your Buy List -- Plus 2 to Avoid,2016-08-10 18:23:00 +0000,https://www.thestreet.com/story/13671525/1/5-big-stocks-to-add-to-your-buy-list-plus-2-to-avoid.html?puc=yahoo&cm_ven=YAHOO,5 Big Stocks to Add to Your Buy List -- Plus 2 to Avoid
MYGN,MYGN:UW,BBG000D9HMX2,Mid-Day Market Update: Crude Oil Down 2%; Clean Energy Fuels Shares Climb Following Upbeat Earnings,2016-08-10 17:39:31 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/NNIER6613FM/mid-day-market-update-crude-oil-down-2-clean-energy-fuels-shares-climb-following-upbeat-earnings-cm663567,"Midway through trading Wednesday, the Dow traded down 0.18 percent to 18,499.60 while the NASDAQ declined 0.45 percent to 5,201.87. The S&P also fell, dropping 0.27 percent to 2,175.88.  Leading and Lagging Sectors"
MYGN,MYGN:UW,BBG000D9HMX2,"Health Care Sector Update for 08/10/2016: HWAY,VSAR,MYGN",2016-08-10 17:25:02 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/TlIALSVSEVY/health-care-sector-update-for-08102016-hwayvsarmygn-cm663556,"Top Health Care Stocks JNJ 0.07% PFE 0.21% MRK 0.62% ABT +0.35% AMGN 0.21% Health care stocks were falling Wednesday, with the NYSE Health Care Index descending about 0.5% while shares of health care companies in the S&P 500"
MYGN,MYGN:UW,BBG000D9HMX2,"MYRIAD GENETICS INC Files SEC form 10-K, Annual Report",2016-08-10 17:09:59 +0000,http://biz.yahoo.com/e/160810/mygn10-k.html,"MYRIAD GENETICS INC Files SEC form 10-K, Annual Report"
MYGN,MYGN:UW,BBG000D9HMX2,"Many 52-Week Lows, Even as Stock Market at All-Time Highs: SunPower, Myriad, Perrigo, Tidewater and More",2016-08-10 16:50:20 +0000,http://247wallst.com/investing/2016/08/10/many-52-week-lows-even-as-stock-market-at-all-time-highs-sunpower-myriad-perrigo-tidewater-and-more/,"Many 52-Week Lows, Even as Stock Market at All-Time Highs: SunPower, Myriad, Perrigo, Tidewater and More"
MYGN,MYGN:UW,BBG000D9HMX2,Why Analysts Are Abandoning Myriad Genetics Upside Hopes,2016-08-10 14:20:06 +0000,http://247wallst.com/healthcare-business/2016/08/10/why-analysts-are-abandoning-myriad-genetics-upside-hopes/,Why Analysts Are Abandoning Myriad Genetics Upside Hopes
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics: 'We Were Wrong',2016-08-10 14:20:00 +0000,http://blogs.barrons.com/stockstowatchtoday/2016/08/10/myriad-genetics-we-were-wrong/?mod=yahoobarrons&ru=yahoo,Myriad Genetics: 'We Were Wrong'
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Lags Q4 Earnings, New Tests Shine",2016-08-10 13:52:18 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/YNdiRQemEt8/myriad-genetics-mygn-lags-q4-earnings-new-tests-shine-cm663268,"Myriad Genetics Inc.MYGN reported adjusted earnings per share (EPS) of 36 cents in the fourth quarter of fiscal 2016, down from the year ago quarter by a nickel. Adjusted EPS also missed the Zacks Consensus Estimate by 5.3%, but"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Stock Tumbles on Q4 Earnings Miss, Guidance",2016-08-10 13:51:00 +0000,https://www.thestreet.com/story/13671095/1/myriad-genetics-mygn-stock-tumbles-on-q4-earnings-miss-guidance.html?puc=yahoo&cm_ven=YAHOO,"Myriad Genetics (MYGN) Stock Tumbles on Q4 Earnings Miss, Guidance"
MYGN,MYGN:UW,BBG000D9HMX2,"Barclays Downgrades Myriad, Says Hereditary Cancer Testing Losses Came Faster Than Expected",2016-08-10 13:19:43 +0000,http://finance.yahoo.com/news/barclays-downgrades-myriad-says-hereditary-131943232.html,"Barclays Downgrades Myriad, Says Hereditary Cancer Testing Losses Came Faster Than Expected"
MYGN,MYGN:UW,BBG000D9HMX2,"Pre-Market Most Active for Aug 10, 2016 :  X, JD, SPWR, PRGO, KORS, FCX, CLF, IAG, MYL, MYGN, QQQ, WEN",2016-08-10 12:58:44 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/CcyWIHmQnnQ/pre-market-most-active-for-aug-10-2016-x-jd-spwr-prgo-kors-fcx-clf-iag-myl-mygn-qqq-wen-cm663065,"The NASDAQ 100 Pre Market Indicator is up 5.11 to 4,800.86. The total Pre Market volume is currently 8,464,810 shares traded. The following are the most active stocks for the pre market session United States Steel Corporation ( X"
MYGN,MYGN:UW,BBG000D9HMX2,"Health Care Sector Update for 08/10/2016: VSAR,MYGN,XLV",2016-08-10 12:52:15 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/IjTa8t3xluo/health-care-sector-update-for-08102016-vsarmygnxlv-cm663057,"Top Health Care Stocks JNJ 0.11% PFE +0.29% MRK 0.08% ABT 0.02% AMGN Unchanged Health care stocks were edging higher Wednesday morning, with shares of health care companies in the S&P 500 measured by the Health Care SPDR ETF"
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics (MYGN) Lags Q4 Earnings, New Tests Shine",2016-08-10 12:44:12 +0000,http://finance.yahoo.com/news/myriad-genetics-mygn-lags-q4-124412506.html,"Myriad Genetics (MYGN) Lags Q4 Earnings, New Tests Shine"
MYGN,MYGN:UW,BBG000D9HMX2,"[$$] With Trio of Exits, Claremont Creek Finds Success in Diagnostics",2016-08-10 11:30:07 +0000,http://www.wsj.com/articles/with-trio-of-exits-claremont-creek-ventures-finds-success-in-diagnostics-1470828604?mod=yahoo_hs,"[$$] With Trio of Exits, Claremont Creek Finds Success in Diagnostics"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. (MYGN) Has Plunged To A New Low After Weak Q4 Report,2016-08-10 09:37:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/dA1hGY-ojbI/myriad-genetics-inc-mygn-has-plunged-to-a-new-low-after-weak-q4-report-20160810-00557,Myriad Genetics Inc. (MYGN) Has Plunged To A New Low After Weak Q4 Report
MYGN,MYGN:UW,BBG000D9HMX2,Myriad misses Street 4Q forecasts,2016-08-09 21:28:45 +0000,http://sg.finance.yahoo.com/news/myriad-misses-street-4q-forecasts-205759843.html,Myriad misses Street 4Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Fiscal Fourth-Quarter 2016 Financial Results,2016-08-09 20:40:09 +0000,http://www.publicnow.com/view/998D4FCEDDCC47B2E1DFFDF6CD79AB325A48DA69,"[at noodls] - Total Revenues of $186.5 Million Adjusted EPS of $0.36 and Diluted EPS of $0.32 Company Issues Fiscal First-Quarter 2017 and Fiscal Year 2017 Financial Guidance SALT LAKE CITY, Aug. 09, 2016 (GLOBE NEWSWIRE) ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Genetics Issues Q1, FY17 Guidance; Shares Plunge",2016-08-09 17:04:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/u6c9fpInD9I/myriad-genetics-issues-q1-fy17-guidance-shares-plunge-20160809-01282,"Myriad Genetics Issues Q1, FY17 Guidance; Shares Plunge"
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Inc. Q4 Profit Drops 10%,2016-08-09 16:09:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/9c6JU--QDnI/myriad-genetics-inc-q4-profit-drops-10-20160809-01127,Myriad Genetics Inc. Q4 Profit Drops 10%
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Q4 16 Earnings Conference Call At 4:30 PM ET,2016-08-09 15:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/nbqwpHYGrFg/myriad-genetics-q4-16-earnings-conference-call-at-430-pm-et-20160809-00945,Myriad Genetics Q4 16 Earnings Conference Call At 4:30 PM ET
MYGN,MYGN:UW,BBG000D9HMX2,What's in Store for Myriad Genetics (MYGN) in Q4 Earnings?,2016-08-05 14:59:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/3WmQUCvgCQo/whats-in-store-for-myriad-genetics-mygn-in-q4-earnings-cm661077,"Myriad Genetics, Inc.MYGN is scheduled to report its fourth quarter fiscal 2016 financial results on Aug 9, after the closing bell. Last quarter, the company posted a positive earnings surprise of 7.89%. Encouragingly, Myriad's earnings outpaced the Zacks Consensus"
MYGN,MYGN:UW,BBG000D9HMX2,"Genomic Health, Inc. Pushes Toward Profitability",2016-08-04 21:56:04 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/GrWFQ_oC43g/genomic-health-inc-pushes-toward-profitability-cm660766,"Image source  Getty Images.  Genomic Health (NASDAQ  GHDX) reported second quarter earnings after the bell on Tuesday, raising the bottom end of the company's 2016 guidance for tests delivered and revenue."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Signs Definitive Agreement to Acquire Assurex Health,2016-08-03 20:22:22 +0000,http://www.publicnow.com/view/833AE977A0D1A156CAF4AABB606159E85E52A02D,"[at noodls] - SALT LAKE CITY, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has signed a definitive agreement ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Announce Fiscal Fourth-Quarter 2016 Financial Results on August 9,2016-07-26 20:28:08 +0000,http://www.publicnow.com/view/BA89693058CB3A4B1AB4FB8AF9D17295BD9ECF1E,"[at noodls] - SALT LAKE CITY, July 26, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it will hold its fiscal fourth-quarter 2016 sales and earnings conference call with investors ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Announces Positive Results for an EndoPredict® Clinical Study Published in the Journal of the National Cancer Institute,2016-07-11 15:43:04 +0000,http://www.publicnow.com/view/50F47F4045E1CCAD801E5A8AC560CE6738979ED0,"[at noodls] - SALT LAKE CITY and COLOGNE, Germany, July 11, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), in collaboration with researchers from the Institute of Cancer Research in London, today announced ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad's myChoice® HRD Test Successfully Identifies Patients that Meet Primary Endpoint in TESARO's Pivotal Phase 3 Ovarian Cancer Study with Niraparib,2016-06-29 11:21:05 +0000,http://www.publicnow.com/view/8E40E62CA17419712A5ADAC7C1E7CFAA0946B7EA,"[at noodls] - SALT LAKE CITY, June 29, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that its myChoice HRD test successfully ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer,2016-06-29 07:27:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/x_d2V5VeAP0/myriad-genetics-mychoice-hrd-test-identifies-patients-with-ovarian-cancer-20160629-00201,Myriad Genetics' MyChoice HRD Test Identifies Patients With Ovarian Cancer
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics To Participate In Goldman Sachs Healthcare Conference At 1:00 PM,2016-06-08 12:00:00 +0000,http://articlefeeds.nasdaq.com/~r/nasdaq/symbols/~3/Blio7eVWKlM/myriad-genetics-to-participate-in-goldman-sachs-healthcare-conference-at-100-pm-20160608-00719,Myriad Genetics To Participate In Goldman Sachs Healthcare Conference At 1:00 PM
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Board Approves $200 Million Increase in Share Repurchase Program,2016-06-07 11:18:07 +0000,http://www.publicnow.com/view/40975219EBF05492BB69E07AD5196378B9A9A200,"[at noodls] - SALT LAKE CITY, June 07, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (Nasdaq:MYGN) announced today that its board of directors has approved an additional $200 million authorization for its share repurchase ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Will Present Three New Hereditary Cancer Studies at the ASCO Annual Meeting,2016-06-05 11:18:01 +0000,http://www.publicnow.com/view/70E20CFD11800FAE8398E9AF68EBA08260531C59,"[at noodls] - SALT LAKE CITY, June 05, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from three studies with ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Acquires Sividon Diagnostics,2016-05-31 20:23:06 +0000,http://www.publicnow.com/view/EF8951E0A99046A61F19320D3D878079AF535C0F,"[at noodls] - SALT LAKE CITY, May 31, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that it has acquired Sividon Diagnostics, ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics' Statement on HIPAA Complaint from Four Patients,2016-05-19 21:02:02 +0000,http://www.publicnow.com/view/AA27EAA4C4100478E7568A746B49284FA1E1BC10,"[at noodls] - SALT LAKE CITY, May 19, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced a complaint was filed against the Company ..."
MYGN,MYGN:UW,BBG000D9HMX2,"Myriad Announces Plans to Launch a Web Portal for Patients that Will Provide Access to Test Results, Tools and Health Information",2016-05-18 22:32:04 +0000,http://www.publicnow.com/view/275FAB12397BF224D1BC6D22C8245EC616974F64,"[at noodls] - SALT LAKE CITY, May 18, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced plans to launch a new web portal on ms360.myriad.com ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Present New Research at the 2016 ASCO Annual Meeting,2016-05-18 22:12:04 +0000,http://www.publicnow.com/view/C3EB1FC23725232180930DAC34E2BFBE7E17CAC3,"[at noodls] - SALT LAKE CITY, May 18, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced it will present data from nine clinical studies with three different products at the 2016 American Society ..."
MYGN,MYGN:UW,BBG000D9HMX2,Crescendo Bioscience Launches Web Portal for Patients with Rheumatoid Arthritis,2016-05-11 11:22:07 +0000,http://www.publicnow.com/view/9B5798CFDFDC24CC6AC01E8410D1E8726087E416,"[at noodls] - myVectra Enables Secure Access to Vectra DA Test Results SOUTH SAN FRANCISCO, Calif., May 11, 2016 (GLOBE NEWSWIRE) -- Crescendo Bioscience, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ:MYGN), ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Present Three New Studies at the AUA Annual Meeting,2016-05-06 11:34:06 +0000,http://www.publicnow.com/view/B52078ECA0E8F4FEE3CE7FB5BC1D52872701D5E6,"[at noodls] - SALT LAKE CITY, May 06, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that results from three studies will be ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Reports Fiscal Third-Quarter 2016 Financial Results,2016-05-03 20:30:17 +0000,http://www.publicnow.com/view/00D16A0A24530084A2ED108BDC5DBFE9290F4792,"[at noodls] - Total Revenues of $190.5 Million Adjusted EPS of $0.41 and Diluted EPS of $0.44 Company Issues Fiscal Fourth-Quarter and Updates Fiscal Year 2016 Financial Guidance SALT LAKE CITY, May 03, 2016 (GLOBE ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad tops Street 3Q forecasts,2016-05-03 20:15:51 +0000,http://sg.finance.yahoo.com/news/myriad-tops-street-3q-forecasts-201551100.html,Myriad tops Street 3Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics to Present at the Bank of America Health Care Conference,2016-05-02 11:30:11 +0000,http://www.publicnow.com/view/AB624382749BD9AECA11ACD27656944E4B4BFE9A,"[at noodls] - SALT LAKE CITY, May 02, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that R. Bryan Riggsbee, chief financial officer, Myriad Genetics, is scheduled to present at the 2016 ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Announces Presentations at the 2016 American Association for Cancer Research Annual Meeting,2016-04-14 11:27:30 +0000,http://www.publicnow.com/view/7CA09B856E56BADB14649975D05E37123C3613A5,"[at noodls] - SALT LAKE CITY, April 14, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that the company and its scientific ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad myRisk® Hereditary Cancer Article in Journal of Clinical Oncology Highlights Importance of Expanding Genetic Testing for Breast Cancer Patients,2016-03-30 11:20:51 +0000,http://www.publicnow.com/view/E9B2BBB89C50DDA18466AEE22682662313A95B1A,"[at noodls] - SALT LAKE CITY, March 30, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, working in collaboration with researchers from the Harvard ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Genetics Teams Up with Access Health® to Educate the Public about Hereditary Cancer and Genetic Testing,2016-03-21 11:27:39 +0000,http://www.publicnow.com/view/83EC889DF7B8276963B3F7912E2A9DDD494649B3,"[at noodls] - SALT LAKE CITY, March 21, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, and Access Health®, an educational program focused on ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad tops Street 2Q forecasts,2016-02-02 21:15:50 +0000,http://sg.finance.yahoo.com/news/myriad-tops-street-2q-forecasts-211550125.html,Myriad tops Street 2Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad to Announce Fiscal Second-Quarter 2016 Financial Results on February 2,2016-01-21 21:19:04 +0000,http://www.noodls.com/view/C83864CDB3ADECB9ABAECEAD518827AD80833430,"[at noodls] - SALT LAKE CITY, Jan. 21, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN) today announced that it will hold its fiscal second-quarter 2016 sales and earnings conference call with investors ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad Advances Prostate and Renal Cancer Molecular Diagnostic Tests at the 2016 ASCO Genitourinary Cancers Symposium,2016-01-07 12:31:10 +0000,http://www.noodls.com/view/8B7FABC9B7AF12385235D303361C945C4B97BA5E,"[at noodls] - SALT LAKE CITY, Jan. 07, 2016 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, today announced that new data will be highlighted on ..."
MYGN,MYGN:UW,BBG000D9HMX2,Myriad beats Street 1Q forecasts,2015-11-03 21:23:35 +0000,http://sg.finance.yahoo.com/news/myriad-beats-street-1q-forecasts-212335727.html,Myriad beats Street 1Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad meets 4Q profit forecasts,2015-08-11 20:46:15 +0000,http://sg.finance.yahoo.com/news/myriad-meets-4q-profit-forecasts-204615696.html,Myriad meets 4Q profit forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad meets 3Q profit forecasts,2015-05-05 21:03:39 +0000,http://sg.finance.yahoo.com/news/myriad-meets-3q-profit-forecasts-210339776.html,Myriad meets 3Q profit forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Ahead of the Bell: Myriad sinks after cutting 2015 forecast,2015-02-04 14:01:03 +0000,http://sg.finance.yahoo.com/news/ahead-bell-myriad-sinks-cutting-140103757.html,Ahead of the Bell: Myriad sinks after cutting 2015 forecast
MYGN,MYGN:UW,BBG000D9HMX2,Myriad beats Street 2Q forecasts,2015-02-03 21:36:50 +0000,http://sg.finance.yahoo.com/news/myriad-beats-street-2q-forecasts-213650313.html,Myriad beats Street 2Q forecasts
MYGN,MYGN:UW,BBG000D9HMX2,Myriad misses Street 1Q forecasts,2014-11-04 21:58:02 +0000,http://sg.finance.yahoo.com/news/myriad-misses-street-1q-forecasts-215802567--finance.html,Myriad misses Street 1Q forecasts
